WO2001089585A1 - tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES - Google Patents

tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES Download PDF

Info

Publication number
WO2001089585A1
WO2001089585A1 PCT/US2001/016678 US0116678W WO0189585A1 WO 2001089585 A1 WO2001089585 A1 WO 2001089585A1 US 0116678 W US0116678 W US 0116678W WO 0189585 A1 WO0189585 A1 WO 0189585A1
Authority
WO
WIPO (PCT)
Prior art keywords
fluorescent
microspheres
polymeric
nanocrystals
microsphere
Prior art date
Application number
PCT/US2001/016678
Other languages
French (fr)
Inventor
Emilio Barbera-Guillem
Stephanie Castro
Original Assignee
Biocrystal Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/577,761 external-priority patent/US6309701B1/en
Priority claimed from US09/633,953 external-priority patent/US6548171B1/en
Application filed by Biocrystal Ltd. filed Critical Biocrystal Ltd.
Priority to AU2001264860A priority Critical patent/AU2001264860A1/en
Publication of WO2001089585A1 publication Critical patent/WO2001089585A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0063Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A61K49/0067Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0063Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots

Definitions

  • This invention relates to polymer-based microspheres, wherein the microspheres are labeled with one or more types of fluorescent nanocrystals.
  • the resulting fluorescent microspheres are useful as distinct tagging agents or as encoders in methods utilizing fluorescence-based detection such as microarrays, high-throughput screening, immunoassays, and flow cytometry.
  • Fluorescent polymeric microspheres have been described as comprising either microspheres which are surface-labeled (including surface-coated) with fluorescent dyes, or micro- spheres having structurally incorporated within their volume (e.g., embedded or polymerized therein) a fluorescent dye.
  • microspheres for a purpose selected from the group consisting of: as a detection reagent with an affinity ligand bound thereto in assaying for the presence of a molecule for which the affinity ligand has binding specificity, as a calibrating agent for calibrating fluorescence-based detection systems, as a tracer (e.g., to trace the flow of a fluid containing the microspheres), and a combination thereof.
  • conventional fluorescent dyes e.g., fluorescein, rhodamine, phycoerythrin, and the like
  • These conventional fluorescent dyes typically have an excitation spectrum that may be quite narrow; hence, it is often difficult to find a wavelength spectrum of light suitable for simultaneously excit- ing several different fluorescent labels (e.g., differing in color of fluorescence emission) .
  • a single light source is used to provide a excitation wavelength spectrum (in view of the spectral line width)
  • there is insufficient spectral spacing between the emission optima of different species (e.g., differing in color) of fluorescent dyes to permit individual and quantitative detection without substantial spectral overlap.
  • fluorescent dyes are susceptible to photobleaching which limits the time in which a fluorescent signal can be detected, and limits time-resolved fluorescence (fluorescent signal integration over time) . Additional limitations of fluorescent dyes include fluorescence quenching, and shifts in fluorescence emission spectra, depending on the environment in which dyes are excited. Fluorescent nanocrystals comprising either semiconductor nanocrystals or doped metal oxide nanocrystals have been reported to resist photobleaching, share an excitation wavelength spectrum, and are capable of emitting fluorescence of high quantum yield and with discrete peak emission spectra.
  • these nanocrystals lack sufficient solubility in aqueous-based environments required for labeling microspheres; i.e., in aqueous-based environments, the nanocrystals interact together in forming aggregates, which leads to irreversible flocculation of the nanocrystals.
  • fluorescent microspheres that: (a) may be used in either single color or multicolor analysis; (b) are comprised of fluorescent nanocrystals which are sufficiently soluble in aqueous-based solutions to permit an effective concentration of the fluorescent nano- crystals to be operably bound to polymeric microspheres in forming fluorescent microspheres; (c) which may be excited with a single wavelength spectrum of light resulting in detectable fluorescence of high quantum yield and with discrete peak emission spectra; (d) that are not susceptible to photobleaching and (e) which may further comprise one or more molecules of affinity ligand for use in fluorescence- based detection systems.
  • a fluorescent microsphere comprised of a polymeric microsphere that is labeled with (operably bound to or having embedded in its surface) a plurality of at least one type of fluorescent nanocrystals, such that following excitation of the fluorescent microsphere with an appropriate excitation wavelength spectrum, the fluorescent microsphere will emit fluorescence of high quantum yield and with discrete peak emission.
  • Fluorescent microspheres may differ in size and composition, and can be varied in the intensity of fluorescence emission and the one or more colors of fluorescence emission by changing the amount and type of fluorescent nanocrystals, respectively, in the method of preparing the microspheres.
  • the fluorescent properties of the fluorescent microspheres is sensitive to the corresponding fluorescent nanocrystals used to produce the fluorescent micro- spheres .
  • a resultant advantage of the fluorescent micro- spheres of the present invention is that they may be produced to have a far greater degree of fluorescence (inten- sity) than previously known fluorescent microspheres. Additionally, the fluorescent microspheres may be used for measuring a plurality of analytes in a single sample.
  • a first population of fluorescent microspheres may be (a) labeled with a plurality of one type of fluorescent nanocrystals which will emit a red fluorescent signal upon excitation, and (b) be tagged with affinity ligand having binding specificity for a first analyte.
  • a second population of fluorescent microspheres may be (a) labeled with a plurality of one type of fluorescent nanocrystals which will emit a yellow fluorescent signal upon excitation, and (b) be tagged with affinity ligand having binding specificity for a second analyte.
  • the two populations of fluorescent microspheres can be mixed within one sample in simultaneously measuring for the presence of the first and second analytes .
  • a single nanocrystal may only be functionalized with a limited number of affinity ligands.
  • a fluorescent microsphere according to the present invention can be labeled with a far greater number of fluorescent nanocrystals in enabling a fluorescent signal much greater in intensity than a single fluorescent nanocrystal can emit.
  • Such an advantage is particularly useful in measuring an analyte which is present in minute quantities (and hence, can be bound by only a limited number of affinity ligand) .
  • more than one type of fluorescent nanocrystal may be used to label the fluorescent microspheres.
  • the fluorescent microspheres may comprise a plurality of types of fluorescent nanocrystals in encoding the fluorescent microspheres with a specific, identifiable code (based on the emission spectra which can comprise both color and intensity) which can be used to distinguish this population of microspheres from a population of fluorescent microspheres which encoded with a different fluorescence pattern.
  • Such encoded fluorescent microspheres are particularly suited for multi- dimensional microarray formats.
  • by controlling the proportion of starting materials e.g., number of polymeric microspheres, and the number and composition of fluorescent nanocrystals
  • precise control may be achieved with respect to the basic fluorescent properties of the resultant fluorescent microspheres .
  • a kit comprising the fluorescent micro- spheres, and may further comprise the fluorescent micro- spheres operably bound to affinity ligand.
  • FIG. 1 is a graph illustrating the relative intensity of an exemplary fluorescent microsphere according to the present invention, as compared to that of a fluorescent nanocrystal.
  • FIG. 2 is a graph illustrating the relative intensity of another exemplary fluorescent microsphere according to the present invention, as compared to that of a fluorescent nanocrystal .
  • analyte is meant, for the purposes of the specification and claims to refer to a molecule of an organic or inorganic nature, the presence and/or quantity of which is being tested for; and which contains a molecular component (domain or sequence or epitope or portion or chemical group or determinant) for which the affinity ligand has binding specificity.
  • the molecule may include, but is not limited to, a nucleic acid molecule, protein, glyco- protein, eukaryotic or prokaryotic cell, lipoprotein, peptide, carbohydrate, lipid, phospholipid, aminoglycans, chemical messenger, biological receptor, structural component, metabolic product, enzyme, antigen, drug, therapeutic, toxin, inorganic chemical, organic chemical, and the like.
  • affinity ligand is meant, for purposes of the specification and claims, to mean a molecule which has binding specificity and avidity for a molecular component of, or associated with, an analyte.
  • affinity ligands are known to those skilled in the art to include, but are not limited to, lectins or fragments (or derivatives) thereof which retain binding function; monoclonal antibodies ("mAb”, including chimeric or genetically modi- fied monoclonal antibodies (e.g., "humanized”)); peptides; aptamers; nucleic acid molecules (including, but not limited to, single stranded RNA or single-stranded DNA, or single- stranded nucleic acid hybrids) ; avidin, or streptavidin, or avidin derivatives; and the like.
  • the invention may be practiced using a preferred affinity ligand (e.g., a mAb) to the exclusion of affinity ligands other than the preferred affinity ligand.
  • a preferred affinity ligand e.g., a mAb
  • the term "monoclonal antibody” is also used herein, for purposes of the specification and claims, to include immunoreactive fragments or derivatives derived from a mAb molecule, which fragments or derivatives retain all or a portion of the binding function of the whole mAb molecule.
  • immunoreactive fragments or derivatives are known to those skilled in the art to include F(ab') 2 , Fab', Fab, Fv, scFV, Fd' and Fd fragments. Methods for producing the various fragments or derivatives from mAbs are well known in the art.
  • F(ab') 2 an be produced by pepsin digestion of the monoclonal antibody, and Fab' may be produced by reducing the disulfide bridges of F(ab') 2 fragments.
  • Fab fragments can be produced by papain digestion of the monoclonal antibody, whereas Fv, single chain antibodies and aptamers can be prepared according to biotechnological methods known in the art. Lectins, and fragments thereof, are commercially available.
  • fluorescent microsphere is meant, for purposes of the specification and claims to refer to a polymeric microsphere labeled with a plurality of fluorescent nanocrystals, wherein the fluorescent microsphere comprises a polymeric microsphere having a plurality of fluorescent nanocrystals operably bound thereto, or comprises a polymeric microsphere having embedded in its surface a plurality of fluorescent nanocrystals.
  • polymeric microsphere is meant, for purposes of the specification and claims to refer to a bead which is substantially spherical in shape, and is comprised of a polymeric material which may include, but is not limited to, latex, acrylic, glass/polymer composites, a thermoplastic (e.g., one or more of polystyrenes, polyvinyl chloride, polyacrylate, nylon, substituted styrenes, poly- amides, polycarbonate, polymethylacrylic acids, polyalde- hydes, and the like) , a magnetic material in combination with a polymeric material, and a combination thereof.
  • a polymeric material which may include, but is not limited to, latex, acrylic, glass/polymer composites, a thermoplastic (e.g., one or more of polystyrenes, polyvinyl chloride, polyacrylate, nylon, substituted styrenes, poly- amides, polycarbonate, polymethylacrylic acids, polyalde- h
  • the polymeric material may further comprise carbon black in a % weight in a range of from about 0.5 to about 5 with respect to the polymeric material, which may minimize (reduce or quench) intrinsic fluorescence of the polymeric material, if any.
  • the carbon black may be mixed into a solution of a thermoplastic, and then the mixture is plasticized into a solid composite.
  • the polymeric microspheres may further comprise one or more molecules of affinity ligand operably bound thereto. Methods for operably binding affinity ligand to the surface of polymeric microspheres are well known in the art.
  • the microspheres will comprise one or more types of reactive functionalities which react with reactive functionalities of an affinity ligand resulting in affinity ligand being operably bound to the polymeric micro- spheres.
  • the one or more types of reactive functionalities present on the surface of the polymeric microsphere comprises a plurality of carboxyl- reactive groups, a plurality of amine-reactive groups, or a combination thereof.
  • the average diameter of the polymeric sphere is in a range of from about 0.05 micron ( ⁇ m) to about 500 ⁇ m; and most preferably, in a range of from about 0.1 ⁇ m to about 10 ⁇ m.
  • composition, shape, size, and density of the polymeric microsphere may vary depending on the factors such as the assay system in which it is used, as well as the nature of an analyte to be detected.
  • a preferred polymeric microsphere may be used to the exclusion of a polymeric microsphere other than the preferred polymeric microsphere .
  • fluorescent nanocrystals is meant, for purposes of the specification and claims to refer to nanocrystals comprising semiconductor nanocrystals or doped metal oxide nanocrystals, wherein the nanocrystals are operably bound to, and functionalized by the addition of, a plurality of molecules which provide the functionalized fluorescent nanocrystals with reactive functionalities to enable the fluorescent nanocrystals to become operably bound to the polymeric microspheres in forming the fluorescent microspheres according to the present invention.
  • a pre- ferred plurality of molecules is selected from the group consisting of carboxylic acid, diaminocarboxylic acid, a monoaminocarboxylic acid, and a combination thereof.
  • a preferred type of molecules may be used to the exclusion of molecules other than the preferred type of molecules.
  • the functionalized nanocrystals are sufficiently soluble in an aqueous-based environment to permit the fluorescent nanocrystals to label (operably bound to or embedded in) the polymeric microspheres in forming fluorescent microspheres in an aqueous-based environment.
  • semiconductor nanocrystals are meant, for purposes of the specification and claims to refer to quantum dots (crystalline semiconductors) comprised of a core comprised of at least one of a Group II-VI semiconductor material (of which ZnS, and CdSe are illustrative examples) , or a Group III-V semiconductor material (of which GaAs is an illustrative example) , a Group IV semiconductor material, or a combination thereof.
  • the core of the quantum dots may be passivated with a semiconductor overlayering ("shell") uniformly deposited thereon.
  • a Group II-VI semiconductor core may be passivated with a Group II-VI semiconductor shell (e.g., a ZnS or CdSe core may be passivated with a shell comprised of YZ wherein Y is Cd or Zn, and Z is S, or Se) .
  • a Group II-VI semiconductor shell e.g., a ZnS or CdSe core may be passivated with a shell comprised of YZ wherein Y is Cd or Zn, and Z is S, or Se
  • the size of the semiconductor core correlates with the spectral range of emission. Table 1 is an illustrative example for CdSe. Table 1
  • the semiconductor nanocrystals are produced using a continuous flow process and system (as disclosed in U.S. Patent No. 6,179,912), and have a particle size that varies by less than +/- 4% in the average particle size.
  • the semiconductor nanocrys- tals comprise a monodisperse population having an average particle size (as measure by diameter) in the range of approximately 1 nanometer (nm) to approximately 20 nm.
  • doped metal oxide nanocrystals is meant, for purposes of the specification and claims to refer to nanocrystals comprised of: a metal oxide, and a dopant comprised of one or more rare earth elements.
  • suitable metal oxides include, but are not limited to, yttrium oxide (Y 2 0 3 ) , zirconium oxide (Zr0 2 ) , zinc oxide (ZnO) , copper oxide (CuO or Cu 2 0) , gadolinium oxide (Gd 2 0 3 ) , praseodymium oxide (Pr 2 0 3 ) , lanthanum oxide (La 2 0 3 ) , and alloys thereof.
  • the rare earth element comprises an element selected from the Lanthanide series and includes, but is not limited to, europium (Eu) , cerium (Ce) , neodymium (Nd) , samarium (Sm) , terbium (Tb) , gadolinium (Gd) , holmium (Ho) , thulium (Tm) , an oxide thereof, and a combination thereof.
  • Eu europium
  • Ce cerium
  • Nd neodymium
  • Sm samarium
  • Tb terbium
  • Gd gadolinium
  • Ho holmium
  • Tm thulium
  • the nature of the rare earth or rare earths are selected in consequence to the color sought to be imparted (emitted) by a doped metal oxide nanocrystal used to label a microsphere according to the present invention.
  • a given rare earth or rare earth combination has a given color, thereby permitting the provision of doped metal oxide nanocrystals, each of which may emit (with a narrow emission peak) a color over an entire range of colors by adjusting the nature of the dopant, the concentration of the dopant, or a combination thereof.
  • the emission color and brightness (e.g., intensity) of a doped metal oxide nanocrystal compri- sing Y 2 0 3 :Eu may depend on the concentration of Eu; e.g., emission color may shift from yellow to red with increasing Eu concentration.
  • concentration of Eu e.g., Eu 1
  • representative colors which may be provided are listed in Table 2. Table 2
  • doped metal oxide nanocrystals are known to include, but are not limited to a sol-gel process, and an organometallic reaction.
  • the dopant e.g., one or more rare earth elements
  • the doped metal oxide nanocrystal are incorporated into the doped metal oxide nanocrystal in a sufficient amount to permit the doped metal oxide nanocrystal to be put to practical use in fluorescence detection as described herein in more detail.
  • An insufficient amount comprises either too little dopant which would fail to emit sufficient detectable fluorescence, or too much dopant which would cause reduced fluorescence due to concentration quenching.
  • the amount of dopant in a doped metal oxide nanocrystal is a molar amount in the doped metal oxide nanocrystal selected in the range of from about 0.1% to about 25%.
  • Doped metal oxide nanocrystals may can be excited with a single excitation light source resulting in a detectable fluorescence emission of high quantum yield (e.g., a single quantum dot having at a fluorescence intensity that may be a log or more greater than that a molecule of a conventional fluorescent dye) and with a discrete fluorescence peak.
  • the doped metal oxide nanocrystals are comprised of metal oxides doped with one or more rare earth elements, wherein the dopant comprising the rare earth element is capable of being excited (e.g., with ultraviolet light) to produce a narrow spectrum of fluorescence emission.
  • the doped metal oxide has both fluorescent properties (when excited with an excitation light source) and magnetic properties; thus, a polymeric microsphere (which is substantially nonmagnetic) operably bound to a plurality of fluorescent nanocrystals (comprising doped metal oxide nanocrystals which are magnetic material) may form fluorescent microspheres according to the present invention which are magnetic.
  • operably bound is meant, for purposes of the specification and claims to refer to fusion or bond or an association of sufficient stability to withstand conditions encountered in a method of detection, between a combi- nation of different molecules such as, but not limited to, between the functionalized nanocrystal and the polymeric microsphere, between a fluorescent nanocrystal and the molecules by which they are functionalized (e.g., carboxylic acid, diaminocarboxylic acid, or a monoaminocarboxylic acid), and a combination thereof.
  • the bond may comprise one or more of covalent, ionic, hydrogen, van der Waals, and the like.
  • Reactive functionalities include, but are not limited to, free chemical groups (e.g., thiol, or carboxyl, hydroxyl, amino, amine, sulfo, etc.), and reactive chemical groups (reactive with free chemical groups) .
  • suitable conditions is used herein, for purposes of the specification and claims, and with reference to a process of reacting two components (e.g., polymeric microsphere and fluorescent nanocrystals; fluorescent microsphere comprising affinity ligand and an analyte for which the affinity ligand has binding specificity) , to mean those conditions under which the components may become operably bound to each other.
  • two components e.g., polymeric microsphere and fluorescent nanocrystals; fluorescent microsphere comprising affinity ligand and an analyte for which the affinity ligand has binding specificity
  • such conditions may include one or more of: a pH range of from about 3 to about 9, ionic strengths such as that ranging from distilled water to about 1 molar sodium chloride, and a temperature in the range of from about 4°C to about 45°C; and may further include a time sufficient for binding to occur (e.g., in a range of from about 10 minutes to about 2 hours) .
  • diaminocarboxylic acid is meant, for purposes of the specification and claims to refer to an amino acid that has two free amine groups.
  • the amino acid may be a naturally occurring amino acid, a synthetic amino acid, a modified amino acid, an amino acid derivative, and an amino acid precursor (e.g., citrulline and ornithine are intermediates in the synthesis of arginine) .
  • the diaminocarboxylic acid contains neutral
  • Exemplary diaminocarboxylic acids include, but are not limited to, lysine, asparagine, glutamine, arginine, citrulline, ornithine, 5- hydroxylysine, djenkolic acid, ⁇ -cyanoalanine, and synthetic diaminocarboxylic acids such as 3 , 4-diaminobenzoic acid, 2, 3-diaminopropionic acid, 2, 4-diaminobutyric acid, 2,5- diaminopentanoic acid, and 2, 6-diaminopimelic acid.
  • amino acid is meant, for purposes of the specification and claims to refer to a molecule that has at least one free amine group and at least one free carboxyl group.
  • the amino acid may have more than one free amine group, or more than one free carboxyl group, or may further comprise one or more free chemical reactive groups other than an amine or a carboxyl group (e.g., a hydroxyl, a sulf- hydryl, etc.) .
  • the amino acid may be a naturally occurring amino acid, a synthetic amino acid, a modified amino acid, an amino acid derivative, and an amino acid precursor.
  • the amino acid may further be selected from the group consisting of a monoaminocarboxylic acid, and a diaminocarboxylic acid.
  • the monoaminocarboxylic acid contains one or more neutral (uncharged) polar functional groups which can hydrogen bond with water, thereby making the monoaminocarboxylic acid (and the quantum dot to which it is made a part of) relatively more soluble in aqueous solutions containing water than those with non-polar functional groups.
  • Exemplary monoaminocarboxylic acids include, but are not limited to, glycine, serine, threonine, cysteine, ⁇ -alanine, homoserine, ⁇ -aminobutyric acid, and homocysteine .
  • carboxylic acid is meant, for purposes of the specification and claims to refer to a compound having the formula HS(CH 2 ) n X, wherein X is a carboxylate (carboxylic moiety) .
  • "n" is a number in the range of from 1 to about 20, and preferably greater than 4.
  • the thiol group of the carboxylic acid can be used as a reactive functionality for the carboxylic acid to become operably bound to the nanocrystal, depending on the composition of the nanocrystal (e.g., to Cd, Zn and the like) .
  • the carboxylic moiety of the carboxylic acid imparts water solubility to the nanocrystals.
  • Exemplary carboxylic acids may include, but are not limited to, mercaptocarboxylic acid, or mercaptofunctionalized amines (e.g., aminoethanethiol-HCl, or 1-amino- -methyl-2- propanethiol-HCl) .
  • Fluorescent nanocrystals comprise nanocrystals which have been functionalized by the addition of a plurality of molecules; and preferably, the molecules are selected from an amino acid, a carboxylic acid, and a combination thereof.
  • the nanocrystals may comprise semiconductor nanocrystals that have a core selected from the group consisting of CdSe, CdS, and CdTe (collectively referred to as "CdX"), and may further comprise a passivating shell comprised of YZ wherein Y is Cd or Zn, and Z is S, or Se.
  • CdX core/YZ shell quantum dots are overcoated with trialkylphosphine oxide, with the alkyl groups most commonly used being butyl and octyl .
  • the CdX cor/YZ shell quantum dots are treated with a large excess of mercaptocarboxylic acid in exchanging the trialkylphosphine oxide coat with a coat comprising a plurality of carboxylic acid molecules.
  • (CdSe) ZnS nanocrystals were prepared in a pyridine solution. The pyridine overcoating of the (CdX) core/YZ shell nanocrystals were exchanged with a carboxylic acid comprising mercaptocarboxylic acid.
  • Exchange of the coating group is accomplished by treating the water-insoluble, pyridine- capped quantum dots with a large excess of neat mercaptocarboxylic acid.
  • the pyridine-capped (CdSe) ZnS quantum dots were precipitated with hexanes, and then isolated by centrifugation. The residue was dissolved in neat mercaptoacetic acid, with a few drops of pyridine added, if necessary, to form a transparent solution. Chloroform was added to precipitate the nanocrystals and wash away excess thiol. The nanocrystals were isolated by centrifugation, washed once more with chloroform, and then washed with hexanes . The residue was briefly dried with a stream of argon.
  • the nanocrystals may then be further functionalized by amino acid comprising a diaminocarboxylic acid.
  • the diaminocar- boxylic acid molecules were operably bound to the carboxylic acid molecules of the nanocrystals by using commercially available crosslinking agents and methods known to those skilled in the art.
  • the carboxylic acid-coated nanocrystals were dissolved in an aqueous buffer system (pH of about 7) .
  • EDC l-ethyl-3-
  • the solution was centrifuged to remove any precipitated solids, and then ultrafiltered through a 30kD MW centrifugal filter.
  • the resultant concentrated, fluorescent nanocrystals can be solubilized in an aqueous solution of choice. Once solu- bilized, the resulting solution can be stored in an amber vial under an inert gas to prevent flocculation.
  • the fluorescent nanocrystals may be operably bound to a suc- cessive layer of amino acid molecules by, for example, repeating the procedure and reaction using EDC and sulfoNHS with the amino acid molecules comprising the successive layer.
  • a nanocrystal comprising a doped metal oxide nanocrystal may be operably bound to a plurality of molecules (e.g., a carboxylic acid, and amino acid, or a combination thereof) using methods known in the art.
  • the plurality of molecules having reactive functionalities comprising free carboxyl groups can be chemi- sorbed, adsorbed or otherwise permanently added to the metal oxide portion of the nanocrystal.
  • the metal oxide nanocrystals are suspended in an aqueous solution of an amino acid comprising homocysteine having a pH of about 3.5 for about an hour. The reaction is then stopped by adjusting the pH to neutral, and dialyzing out the aqueous solution.
  • the mixture was stirred to dissolve the homocysteine, and then stored at 4°C for 24 hours.
  • the resultant solution was then centrifuged to remove any precipitate, and the supernatant was transferred to a centrifugal filter for the appropriate volume of supernatant (preferably, with a molecular weight cutoff of about 10 kD or below to retain the fluorescent nanocrystals coated with homocysteine) .
  • the fluorescent nanocrystals were then rediluted in the appropriate aqueous solution (e.g., HEPES buffer) to a volume in which the original mass of homocysteine had been dissolved.
  • the steps of filtering and redilution of the fluorescent nanocrystals in solution may be repeated to improve purity.
  • the resultant fluorescent nanocrystals comprising homocysteine-coated nanocrystals may then be degassed by bubbling with an inert gas, and then stored at
  • EXAMPLE 2 This example illustrates one embodiment of fluorescent microspheres, and a method of making the fluorescent micro- spheres, according to the present invention.
  • polymeric microspheres are labeled with fluorescent nanocrystals by contacting the polymeric microspheres with fluorescent nanocrystals under suitable conditions for the fluorescent nanocrystals to become operably bound to the polymeric microspheres in forming fluorescent microspheres .
  • each polymeric microsphere comprises multiple molecules of reactive functionality comprising a free chemical group
  • the fluorescent nanocrystals comprise multiple molecules of reactive functionality comprising reactive chemical groups which are capable of becoming operably bound to the reactive functionality of the polymeric microsphere under suitable conditions so that a plurality of fluorescent nanocrystals become operably bound to a polymeric microsphere in forming a fluorescent micro- sphere.
  • the polymeric microspheres comprise a reactive functionality comprising an amino group
  • the fluorescent nanocrystals comprise a reactive functionality comprising an amino-reactive group (e.g., carboxyl or amine) .
  • the polymeric microspheres comprise a reactive functionality comprising a thiol group and the fluorescent nanocrystals comprise a reactive functionality comprising a thiol-reactive group (e.g., amine group) .
  • the polymeric microsphere used in this illustration comprised amine-activated polystyrene-based beads of a size of about 8.8 ⁇ m. More particularly, their composition comprised 25% styrene, 55% divinylbenzene, 20% glycidylmeth- acrylate, which was activated with ethylenediamine. Approximately 2.7 x 10 s polymeric microspheres (in a volume of 100 ⁇ l aqueous solution) was mixed with 10 ⁇ l of a 10 ⁇ M fluorescent nanocrystal solution, and the mixture was gently agitated at room temperature for 20 minutes.
  • the resultant fluorescent microspheres formed were then collected by centrifugation (e.g., 2 minutes at 2000 x g) , washed with an aqueous solution, and then collected by centrifugation again.
  • the resultant microspheres were suspended in a non- aqueous medium (e.g., dimethylsulfoxide, or mineral oil, or heptane) and placed onto a slide for viewing under a fluorescence microscope.
  • a non- aqueous medium e.g., dimethylsulfoxide, or mineral oil, or heptane
  • the solution containing the resultant microspheres was dried onto a slide for viewing under a fluorescence microscope.
  • Table 3 are illustrative of the fluorescence emitted by fluorescent microspheres according to the present invention.
  • Type 1 fluorescent microspheres comprise fluorescent nanocrystals (homocysteine-coated (CdSe) ZnS) operably bound to amine- activated polymeric microspheres; type 2 fluorescent micro- spheres comprise fluorescent nanocrystals (homocysteine- coated (CdSe) ZnS; different in size than type 1) operably bound to amine-activated polymeric microspheres; type 3 fluorescent microspheres comprise fluorescent nanocrystals (mercaptocarboxylic acid-coated (CdSe) ZnS) operably bound to amine-activated polymeric microspheres; type 4 fluorescent microspheres comprise fluorescent nanocrystals ((CdSe) ZnS nanocrystals comprising a first coat comprising mercaptocarboxylic acid, and a second coat comprising diaminocar- boxylic acid) operably bound to amine-activated polymeric microspheres; and a control comprising polymeric micro- spheres alone.
  • the fluorescence analyses
  • FIG. 1 illustrates the relative intensity over time after excitation (arrow) of an exemplary fluorescent microsphere as compared to that of a comparative fluorescent nanocrystal used in producing a fluorescent microsphere.
  • This example illustrates embodiments of fluorescent microspheres, and a method of making the fluorescent micro- spheres, according to the present invention; wherein polymeric microspheres are labeled with fluorescent nanocrystals by contacting the polymeric microspheres with fluorescent nanocrystals under suitable conditions for the fluorescent nanocrystals to become embedded into the polymeric micro- spheres in forming fluorescent microspheres.
  • the polymeric microspheres are first exposed to conditions suitable for swelling them in size (e.g., also referred to as "expanded") so as to increase porosity in allowing fluorescent nanocrystals, present in the reaction process, to enter into pores at the surface of each swollen polymeric microsphere.
  • the polymeric microspheres are then exposed to suitable conditions in which the polymeric microspheres become unswollen, thereby physically entrapping the fluorescent nanocrystals in the pores of the polymeric microspheres.
  • the fluorescent nanocrystals become embedded in the surface of a polymeric microsphere.
  • the polymeric micro- spheres are swelled by exposing them to a temperature sufficient to soften the polymer composition of the polymeric microspheres, but below the melting point of the polymer composition.
  • the suitable conditions may further comprise pressurizing the polymeric microspheres (e.g., to a pressure above atmospheric pressure) which can be used to shorten the time in which to heat the polymeric microspheres to make them swell.
  • Suitable conditions for swelling polymeric microspheres to physically entrap fluorescent nanocrystals can be determined using methods customary in the art. As will be apparent to those skilled in the art, the time and temperature used to swell the polymeric microspheres will depend on the nature (e.g., composition) of the polymeric microspheres.
  • polymeric microspheres comprised of polystyrene can be softened at temperatures in the range of from about 200°C to about 250 °C for a time of about 0.5 to about 10 hours (depending on the type of polystyrene) .
  • the amount of superatmospheric pressure to which the polymeric microspheres may be exposed will depend on the temperature of heating, and the nature (e.g., composition) of the polymeric microspheres.
  • the polymeric microspheres capable of being swelled to increase porosity are added to a solution containing the fluorescent nanocrystals, wherein the resultant reaction suspension is contained within a reaction vessel.
  • reaction suspension in the reaction vessel is then subjected to suitable conditions (e.g., heat, or heat and pressuriza- tion) to effect swelling of the polymeric microspheres and entry of the fluorescent nanocrystals into the pores of the swelled polymeric microspheres.
  • suitable conditions e.g., heat, or heat and pressuriza- tion
  • the reaction is stopped (e.g., allow the suspension to cool to ambient temperature; or cooling with venting to reduce pressure to atmospheric) resulting in the unswelling of the polymeric microspheres, and the physical entrapment of fluorescent nanocrystals in forming fluorescent microspheres having a uniform distribution of fluorescent nanocrystals embedded therein.
  • the process may further comprise purifying the fluorescent microspheres from any free fluorescent nanocrystals in the reaction suspension (e.g., by one or more of: size such as by centrifugation, size exclusion chromatography, and the like; by affinity chromatography if the fluorescent micro- spheres further comprise affinity ligand) .
  • size such as by centrifugation, size exclusion chromatography, and the like
  • affinity chromatography if the fluorescent micro- spheres further comprise affinity ligand
  • the ratio of fluorescent nanocrystals to polymeric microspheres may vary with factors which include, but are not limited to, the size of the polymeric microspheres, the desired fluorescent intensity of the resultant fluorescent microspheres, and the like.
  • the fluorescent nanocrystals are in a sufficient amount to saturate the surface of each polymeric microsphere present in the reaction. While not intended to be limiting, generally the amount of fluorescent nanocrystals in the reaction is less than or equal to about 20% by weight of the polymeric microspheres in the reaction.
  • the polymeric microspheres are swelled by exposing them to an organic medium comprising one or more organic solvents which are able to swell the polymeric microspheres.
  • the degree of swelling necessary for physically entrapping the fluorescent nanocrystals in the polymeric microspheres can be adjusted by the type and amount of solvent using customary methods.
  • the time of exposure to, and concentration of, the one or more solvents used to swell the polymeric microspheres will depend on the nature of the composition of the polymeric microspheres, and the composition of the organic medium used.
  • a wide variety of common liquid organic solvents can be used to swell polymeric microspheres in a controlled manner so as not to permanently damage the polymeric microspheres themselves.
  • Useful solvents may include, but are not limited to, dimethyl sulfoxide (DMSO) , dimethyl- formamide (DMF) , toluene, tetrahydrofuran, chloroform, methylene chloride, acetones, acetonitrile, alcohols, or a combination thereof.
  • the organic medium is water-miscible.
  • the organic medium is in a concentration of 30% or more (v/v) for performing the swelling.
  • the polymeric microspheres capable of being swelled to increase porosity are added to organic medium comprising the one or more solvents, and also containing the fluorescent nanocrystals, wherein the resultant reaction suspension is contained within a reaction vessel for a sufficient time to effect the swelling of the polymeric microspheres.
  • the reaction is stopped (e.g., by removing the organic medium from contacting the polymeric microspheres) resulting in unswelling of the polymeric microspheres, and the physical entrapment of fluorescent nanocrystals in forming fluorescent microspheres having a uniform distribution of fluorescent nanocrystals embedded therein.
  • the process may further comprise purifying the fluorescent microspheres from any free fluorescent nanocrystals in the reaction suspension (e.g., by one or more of: size such as by centrifugation, size exclusion chromatography, and the like; by affinity chromatography if the fluorescent microspheres further comprise affinity ligand) .
  • size such as by centrifugation, size exclusion chromatography, and the like
  • affinity chromatography if the fluorescent microspheres further comprise affinity ligand
  • the reaction is carried out at a temperature in the range of from about 5°C to about 30°C during a sufficient period of time for the organic medium to diffuse or absorb into the polymeric microspheres to cause their swelling.
  • the ratio of fluorescent nanocrystals to polymeric microspheres may vary with factors which include, but are not limited to, the size of the polymeric microspheres, the desired fluorescent intensity of the resultant fluorescent microspheres, and the like.
  • the fluorescent nanocrystals are in a sufficient amount to saturate the surface of each polymeric microsphere present in the reaction. While not intended to be limiting, generally the amount of fluorescent nanocrystals in the reaction is less than or equal to about 20% by weight of the polymeric microspheres in the reaction.
  • the swellable polymeric microspheres (and the resultant fluorescent microspheres) further comprise multiple molecules of reactive functionality comprising a free chemical group which may include, but is not limited to, carboxyl, amine, amide, tiol, ester, sulfhydryl, and the like.
  • the surface reactive functionalities of a fluorescent microsphere may be used as a means for operably binding affinity ligand to the fluorescent microsphere, wherein the affinity ligand has a free chemical group which is reactive (in forming a bond) with the surface reactive functionalities of the microsphere.
  • affinity ligand that may be operably bound to the surface of the fluorescent micro- spheres may include, but are not limited to, antibody, avidin, biotin, protein A or G, lectin, aptamer, a nucleic acid molecule (e.g., RNA, DNA, hybrids, single stranded, double stranded, synthetic, oligonucleotides, etc.), a carbohydrate chain, a protein with binding specificity for an analyte, and the like.
  • a nucleic acid molecule e.g., RNA, DNA, hybrids, single stranded, double stranded, synthetic, oligonucleotides, etc.
  • carbohydrate chain e.g., a protein with binding specificity for an analyte, and the like.
  • the fluorescent microspheres that further comprise affinity ligand are then used as a detection reagent in an assay for determining the presence or absence of an analyte for which the affinity ligand has binding specificity, as is disclosed herein in more detail.
  • This example illustrates an embodiment of the fluorescent microspheres according to the present invention, as well as a process for making the fluorescent microspheres.
  • the polymeric microspheres used in this illustration comprised amine-activated polystyrene-based beads of a size of about 7.3 ⁇ m. More particularly, their composition comprised 70% methylmethacrylate, 20% glycidylmethacrylate, and 10% ethylene glycol dimethacrylate.
  • a 10% (w/w) suspension of the polymeric microspheres (in a volume of 10 ⁇ l) was diluted in a reaction vessel with an organic medium comprised of either of two solvents, DMSO or DMF (90 ⁇ l) .
  • an organic medium comprised of either of two solvents, DMSO or DMF (90 ⁇ l) .
  • To each was added 10 ⁇ l of a 10 ⁇ M fluorescent nanocrystal solution (in an aqueous buffer; e.g., HEPES), and the resultant reaction suspension was mixed and incubated at room temperature for a sufficient time for swelling of the polymeric microspheres. Although a sufficient time may comprise only minutes, in this case the reaction was allowed to proceed for a time that ranged from about 1 hour to about 24 hours.
  • the reactions were stopped by adding to the respective reaction suspension a water-based buffer or water, and then removing the solvent.
  • a water-based buffer or water was added, and mixed with, 1 ml of HEPES buffer, followed by pelleting the resultant fluorescent microspheres by centrifugation (e.g., 2 minutes at 2000 x g) .
  • Each preparation of fluorescent microspheres was washed again with the buffer, and then collected by centrifugation.
  • Each of the preparations of fluorescent microspheres was then resuspended in 20 ⁇ l of buffer.
  • each of the preparations of fluorescent micro- spheres was suspended in a non-aqueous medium (e.g., formalin solution (4% formaldehyde) , dimethylsulfoxide, or mineral oil) and placed onto a microscopic slide for viewing under a fluorescence microscope. After excitation with ultraviolet light, and using a 425 nm long pass emission filter, each of the preparation of fluorescent microspheres was observed under fluorescent microscopy as being a strong red fluorescence (614 nm) , characteristic of the fluorescent nanocrystals (homocysteine-coated (CdSe) ZnS) embedded in the fluorescent microspheres.
  • a non-aqueous medium e.g., formalin solution (4% formaldehyde) , dimethylsulfoxide, or mineral oil
  • FIG. 2 illustrates the relative intensity of an exemplary fluorescent microspheres ("FM") compared to that of comparative fluorescent nanocrystals ("NC") used in producing the fluorescent microspheres, expressed as a ratio of FM:NC, and with respect to concen- tration of analyte ("antigen").
  • FM fluorescent microspheres
  • NC comparative fluorescent nanocrystals
  • antigen analyte
  • EXAMPLE 4 This example illustrates another embodiment of fluores- cent microspheres, and a method of making the fluorescent microspheres, according to the present invention; wherein polymeric microspheres are contacted with fluorescent nanocrystals under suitable conditions for forming fluorescent microspheres, and wherein the fluorescent microspheres fur- ther comprise a plurality of molecules of affinity ligand which are contacted with the fluorescent microspheres under suitable conditions for the affinity ligand to be operably bound to the fluorescent microspheres.
  • the polymeric micro- spheres have affinity ligand operably bound thereto before fluorescent nanocrystals are operably bound to the polymeric microspheres in producing fluorescent microspheres according to the present invention.
  • fluorescent microspheres are produced first (e.g., by opera- bly binding the fluorescent nanocrystals to, or embedding the fluorescent nanocrystals in, the polymeric micro- spheres) , and then the affinity ligand is operably bound to the fluorescent microspheres.
  • fluorescent microspheres were made according to the methods described in Example 2 herein. To approximately 1.4 x 10 7 fluorescent microspheres (in a volume of 500 ⁇ l aqueous solution) was added 2 mg of EDC (in 100 ⁇ l aqueous solution) and 5 mg sulfo-NHS (in 100 ⁇ l aqueous solution), and the mixture was mixed for 10 minutes.
  • the observed binding included large aggregates of beads and microspheres together. Few instances of non-specific aggregation were observed.
  • neutravidin was operably bound to the fluorescent microspheres
  • a dot blot was performed in a microfuge tube. Approximately 1.4 x 10 6 fluorescent microspheres were placed in a 1.5 ml microfuge tube. Added to the tube was a blocking solution (1% dry non-fat milk, 0.05% detergent, in buffer) for an incubation of 1 hour. The fluorescent microspheres were then pelleted by centrifugation.
  • the fluorescent microspheres were then resuspended in 1 ⁇ g/ml biotin-labeled rabbit anti-mouse IgG in blocking solution, incubated for one hour, and then followed by several cycles of pelleting and washing.
  • the fluorescent microspheres were then resuspended in 1 ⁇ g/ml horseradish peroxidase-labeled goat anti-rabbit-IgG in blocking solution, incubated for one hour, and then followed by several cycles of pelleting and washing.
  • the fluorescent microspheres were then resuspended in a color development reagent (DAB) for 15 minutes, and then washed to remove excess color development solution. By visual examination, the fluorescent microspheres were strongly stained dark brown, indicating that neutravidin was operably bound to the surface of the fluorescent microspheres .
  • DAB color development reagent
  • the polymeric microspheres are swell- ed and unswelled under suitable conditions so as to physically entrap fluorescent nanocrystals in forming fluorescent microspheres, and wherein the fluorescent microspheres further comprise a plurality of molecules of affinity ligand which are contacted with the fluorescent microspheres under suitable conditions for affinity ligand to be operably bound to the fluorescent microspheres.
  • the fluorescent microspheres are formed first, and then affinity ligand is operaly bound thereto in producing fluorescent microspheres further com- prising affinity ligand according to the present invention.
  • fluorescent microspheres are made according to one of the methods described in Example 3 herein.
  • EDC in 100 ⁇ l aqueous solution
  • sulfo-NHS in 100 ⁇ l aqueous solution
  • Mercaptoethanol 1 ⁇ l
  • Affinity ligand in this illustrative embodiment, neutravidin; 10 ⁇ g
  • TRIS (30mM) is then added to the mixture with stirring for 30 minutes .
  • the resultant fluorescent microspheres are then pelleted by centrifugation, washed several times in aqueous solution to wash away free neutravidin, and then resuspended in an aqueous solution.
  • affinity ligand may be operably bound to fluorescent microspheres while retaining the ability of the bound affinity ligand to interact with analyte for which it has binding specificity.
  • EXAMPLE 6 This example illustrates another embodiment of fluorescent microspheres according to the present invention, and further illustrates a method of making the fluorescent microspheres according to the present invention.
  • the fluorescent microspheres comprised fluorescent nanocrystals which label (operably bound to or embedded in the surface of) polymeric microspheres comprising a magnetic responsive material ("magnetic material") with a polymeric, nonmagnetic coating.
  • magnetic material a magnetic responsive material
  • Such polymeric microspheres are known to include general characteristics as follows.
  • magnetic materials useful for the microspheres may include, but are not limited to, ferromagnetic, ferrimagnetic, paramagnetic, superparamagnetic materials, and the like.
  • Such magnetic materials may include, but are not limited to: metals, such as nickel, iron, cobalt, chromium, manganese, and the like; lanthanide series elements, such as neodymium, erbium, and the like; alloys such as magnetic alloys of metals; metal oxides, such as ferric oxide, chromium oxide, nickel oxide, and the like; composites, such as ferrites, magnetite, and the like; and combinations thereof.
  • the diameter of a core of magnetic material core may vary widely depending on the size of the polymeric microsphere of which it is a part; the composition, shape, size and density of the magnetic material; and the assay protocol in which the polymeric microsphere is used.
  • the diameter of a magnetic material core is a size in the range of from about 0.01 ⁇ m to about 10 ⁇ m.
  • Polymeric materials into which may be embedded the magnetic material, or with which may be used to coat a magnetic material core, have been previously described herein in more detail.
  • the polymeric microspheres comprising magnetic material may comprise: a magnetic material core and a polymeric, nonmagnetic coating; a nonmagnetic core (e.g., polymeric or other nonmagnetic material) with a magnetic material layer thereon, and a polymeric, nonmagnetic coating; a magnetic material embedded within a polymeric, nonmagnetic material; and a magnetic material dispersed within a polymeric, nonmagnetic material (such as may be obtained by mixing the magnetic material into a solution of a thermoplastic, and then plasticizing the mixture into a solid composite) .
  • a nonmagnetic core e.g., polymeric or other nonmagnetic material
  • a magnetic material embedded within a polymeric, nonmagnetic material e.g., polymeric or other nonmagnetic material
  • a magnetic material dispersed within a polymeric, nonmagnetic material such as may be obtained by mixing the magnetic material into a solution of a thermoplastic, and then plasticizing the mixture into a solid composite
  • the commercially-obtained polymeric microspheres comprised polymer-coated magnetite which were also coated with affinity ligand (either strept- avidin (2.8 ⁇ m diameter), or goat anti-mouse I G (4.5 ⁇ m diameter) on the surface of the microspheres.
  • affinity ligand either strept- avidin (2.8 ⁇ m diameter), or goat anti-mouse I G (4.5 ⁇ m diameter) on the surface of the microspheres.
  • Fluorescent microspheres comprise fluorescent nanocrystals (e.g., homocysteine-coated (CdSe) ZnS) operably bound to the magnetic polymeric microspheres having streptavidin operably bound thereto ("type A”); fluorescent microspheres comprise fluorescent nanocrystals (e.g., homocysteine-coated (CdSe) ZnS; different in size than type A) operably bound to magnetic polymeric microspheres having streptavidin operably bound thereto ("type B”); fluorescent microspheres comprise fluorescent nanocrystals (e.g., mercaptocarboxylic acid- coated (CdSe) ZnS) operably bound to magnetic polymeric microspheres having streptavidin operably bound thereto
  • fluorescent microspheres comprise fluorescent nanocrystals (e.g., (CdSe) ZnS nanocrystals comprising a first coat comprising mercaptocarboxylic acid, and a second coat comprising diaminocarboxylic acid) operably bound to magnetic polymeric microspheres having streptavidin operably bound thereto ("type D”); a control "A” comprising only polymeric microspheres having streptavidin operably bound thereto; fluorescent microspheres comprise fluorescent nanocrystals (e.g., mercaptocarboxylic acid-coated (CdSe) ZnS) operably bound to magnetic polymeric microspheres having antibody (IgG) operably bound thereto ("type E” ) ; fluorescent microspheres comprise fluorescent nanocrystals (e.g., (CdSe) nS nanocrystals comprising a first coat comprising mercaptocarboxylic acid, and a second coat comprising diaminocarbox
  • the following example illustrates (a) a test that affinity ligand of the polymeric microspheres was still functional (e.g., could bind to analyte for which it has binding specificity) after fluorescent nanocrystals were operably bound to the polymeric microspheres in forming fluorescent microspheres according to the present invention; and (b) a method of using the fluorescent microspheres to detect an analyte in a sample.
  • fluorescent nanocrystals may be operably bound to polymeric microspheres comprising affinity ligand in forming fluorescent microspheres which retain the ability of the affinity ligand to interact with a analyte for which it has binding specificity.
  • commercially-obtained polymeric microspheres comprising polymer-coated magnetite may be used in the process according to Examples 3 & 4 herein, in physically entrapping fluorescent nanocrystals in forming fluorescent microspheres.
  • the resultant fluorescent microspheres may further comprise affinity ligand by using a process according to Examples 4 & 5 herein.
  • EXAMPLE 7 This example illustrates one embodiment of a method of using the fluorescent microspheres according to the present invention to provide an identifiable fluorescence signal pattern.
  • semiconductor nanocrystals can be produced in several uniform sizes, with each size comprising a homogeneous population capable of emitting a discrete fluorescence emission of high quantum yield (i.e., the particular color emitted is primarily dependent on the size of the nanocrystal) , but wherein the heterogeneous population (a combination of homogeneous populations) can be excited with a single wavelength spectrum of light, and can emit a distinguishably detectable (“discrete”) fluorescence emission spectra representative of the homogenous populations.
  • a homogeneous population e.g., containing the same type and amount of dopant
  • the heterogeneous population a combination of homogeneous populations
  • a fluorescent microsphere may comprise an identifiable fluorescence signal pattern comprised of one (e.g., capable of fluores- cing a single color) or more (capable of fluorescing in multicolor) homogeneous populations of fluorescent nanocrystals which comprise a part (component) of the fluorescent microsphere.
  • the fluorescent naocrystals may be dispersed over the general shape of the fluorescent micro- sphere, or may be spatially arranged (e.g., multiple deposits ("localizations") on the polymeric microsphere which may be controlled by controlling the availability and location of reactive functionalities on the polymeric micro- sphere to which the fluorescent nanocrystals become operably bound) in providing a fluorescence signal pattern comprised of a single color of fluorescence, and as measured by a peak intensity.
  • localizations multiple deposits
  • the fluorescent nanocrystals may be dispersed over the general shape of the fluorescent microsphere, or may be spatially arranged (e.g., multiple deposits ("localizations") on the polymeric microsphere which may be controlled by controlling the availability and location of reactive functionalities on the polymeric microsphere to which the fluorescent nanocrystals become operably bound) in providing a fluorescence signal pattern comprised of more than one color of (multicolor) fluorescence with each color capable of being detectably distinguishable from the other colors.
  • localizations multiple deposits
  • the fluorescent nanocrystals may be dispersed by physical entrapment to cover the general shape of the fluorescent microsphere in providing a fluorescence signal pattern comprised of a single color of fluorescence, and as measured by a peak intensity.
  • the fluorescent nanocrystals may be dispersed by physical entrapment to cover the general shape of the fluorescent microsphere in providing a fluorescence signal pattern comprised of more than one color of (multicolor) fluorescence with each color capable of being detectably distinguishable from the other color or colors by their peak emission spectra (e.g., are spectrally resolvable) .
  • a fluorescence signal pattern emitted by one or more fluorescent microspheres may comprise a fluorescence signal pattern comprised of detectably distinguishable intensities of one or more colors.
  • a code representative of the fluorescence signal pattern, and of the one or more fluorescent microspheres emitting the fluorescence signal pattern may comprise an identifier (e.g., one or more numbers) for each color comprising the fluorescence signal pattern, and may further comprise an identifier representative of the intensity of each color comprising the fluorescence signal pattern (e.g., wherein the code comprises a combination of the identifiers, such as a string of numbers in a range of from about 2 numbers to about 100 numbers) .
  • an identifiable fluorescence signal pattern comprised of a plurality of colors (or colors and intensities) enables a large number of combinations and permutations which may be used to identify or track fluorescent microspheres exposed to an exciting light source and detection of the resultant fluorescence emission.
  • fluorescent microspheres may be used in multidimensional array formats (e.g., micro- arrays) for detecting a plurality of analytes by depositing on and/or flowing the fluorescent microspheres in the desired array format, and utilizing an appropriate detection system to detectably distinguish the fluorescent signal patterns (e.g., as measured by number of events of fluorescence versus the intensity of fluorescence, using a fluorescence microscope with a video camera attachment and computer software program for manipulating and storing the data collected) .
  • EXAMPLE 8 This example illustrates another embodiment of a method of using the fluorescent microspheres according to the present invention for determining the presence or absence of a predetermined number of analytes in a sample.
  • the determination may be qualitative or quantitative, depending on the assay format utilized.
  • a predetermined number of analytes means a single analyte if it is desired to determine the presence or absence of that analyte alone; or more than one analyte when it is desired to determine the presence or absence of any one of multiple analytes.
  • the fluorescent microspheres may comprise a homogenous population which is capable of fluorescing a peak emission (fluorescent signal pattern) when excited by an excitation light source, and further comprises affinity ligand having binding specificity for the analyte of which the presence or absence is to be determined.
  • the fluorescent micro- spheres may comprise a heterogeneous population comprising multiple homogenous populations, wherein each homogenous population is capable of emitting a fluorescence signal pattern distinguishable from the fluorescence signal pat- terns of other homogenous populations comprising the heterogeneous population, and wherein the heterogeneous population may be excited by a single excitation light source.
  • Each homogenous population may further comprise affinity ligand having binding specificity for an analyte of the predeter- mined number of analytes of which the presence or absence is to be determined.
  • a method of using the fluorescent microspheres for determining the presence or absence of a predetermined number of analytes in a sample comprises:
  • the method may further comprise quan- titating the amount of analyte by measuring the intensity of the fluorescence signal pattern emitted from the fluorescent microspheres bound to the analyte, and relating the intensity measured to the amount of analyte.
  • the method may be used in a fluorescent detection system selected from the group consisting of an affinity-based assay, fluorescence- based immunoassay, fluorescent staining (e.g., immuno- fluorescent staining on a glass slide) , flow cytometry, a hybridization-based assay, and the like.
  • a fluorescent detection system selected from the group consisting of an affinity-based assay, fluorescence- based immunoassay, fluorescent staining (e.g., immuno- fluorescent staining on a glass slide) , flow cytometry, a hybridization-based assay, and the like.
  • the fluorescence signal pattern comprises one or more fluorescence emission peaks, wherein each peak has a narrow spectral band (e.g. between about 4 nm to about 50 nm) in the range of from about 400 nm to about 800 nm.
  • a preferred excitation light source for exciting the fluorescent microspheres according to the present invention is in the range of about 300 nm to about
  • Any fluorescence signal pattern emitted is then detected and imaged by appropriate detection means or system (e.g., one or more of: photodetector, filter, charge couple device camera (CCD camera) fluorimeter, fluorescence microscope, a fluorescence cube, a computer for manipulating fluorescence signal pattern data collected, and a combination thereof) .
  • detection means or system e.g., one or more of: photodetector, filter, charge couple device camera (CCD camera) fluorimeter, fluorescence microscope, a fluorescence cube, a computer for manipulating fluorescence signal pattern data collected, and a combination thereof.
  • kits which comprises one or a combination of types of fluorescent microspheres according to the present invention.
  • a kit may be provided which comprises one or more separate containers, wherein each container has contents comprising fluorescent microspheres capable of fluorescing a specific fluorescence pattern (e.g., one color or a desired combination of colors) .
  • the fluorescent microspheres may comprise reactive functionalities which allow a user of the kit to operably bind affinity ligand of the user's choice to the fluorescent microspheres.
  • the kit may provide the user with the flexibility to prepare a customized detection reagent comprising the fluorescent microspheres operably bound to affinity ligand of the user's choice.
  • the kit may comprise 3 containers, wherein one container has contents comprising fluorescent microspheres capable of fluorescing red; a second container has contents comprising fluorescent micro- spheres capable of fluorescing yellow; a third container has contents comprising fluorescent microspheres capable of fluorescing green; wherein the contents of each container are capable of being operably bound to affinity ligand via the reactive functionalities of the respective type (e.g., fluorescing color) of fluorescent microspheres.
  • the different types e.g., the three types distinguished above by color of fluorescence/specific fluorescence pattern
  • the fluorescent microspheres contained in each separate container comprising the kit further comprise affinity ligand operably bound thereto.
  • the fluorescent microspheres may be used as detection reagents as described herein in more detail.
  • the kit may comprise a single container having contents comprising fluorescent microspheres further comprising affinity ligand having binding specificity for a desired analyte; or may comprise more than one type of fluorescent microspheres wherein each individual type has affinity ligand having a different binding specificity than affinity ligand of the other types of fluorescent microspheres in the single container.
  • each of plurality of types of fluorescent microspheres may be individually packaged in a separate container, such that the kit is now comprised of a plurality of containers .

Abstract

Provided are a fluorescent microsphere comprised of a polymeric microsphere labelled with a plurality of fluorescent nanocrystals, and a method of producing the fluorescent microspheres which comprises contacting the polymeric microsphere with a plurality of fluorescent nanocrystals under suitable conditions in which the fluorescent nanocrystals become operably bound to or embedded in the polymeric microsphere. Also provided is a method of using the fluorescent microspheres capable of determining the presence or absence of a predetermined number of analytes in a sample by contacting the sample with the fluorescent microspheres, and detecting the fluorescence signal pattern of excited fluorescent microspheres bound to one or more analytes of the predetermined number of analytes, if present in the sample.

Description

FLUORESCENT NANOCRYSTAL- ABELED MICROSPHERES FOR FLUORESCENCE ANALYSES
FIELD OF THE INVENTION
This invention relates to polymer-based microspheres, wherein the microspheres are labeled with one or more types of fluorescent nanocrystals. The resulting fluorescent microspheres are useful as distinct tagging agents or as encoders in methods utilizing fluorescence-based detection such as microarrays, high-throughput screening, immunoassays, and flow cytometry.
BACKGROUND OF THE INVENTION Fluorescent polymeric microspheres have been described as comprising either microspheres which are surface-labeled (including surface-coated) with fluorescent dyes, or micro- spheres having structurally incorporated within their volume (e.g., embedded or polymerized therein) a fluorescent dye. Commonly used fluorescence-based analyses that utilize fluorescent microspheres generally apply the microspheres for a purpose selected from the group consisting of: as a detection reagent with an affinity ligand bound thereto in assaying for the presence of a molecule for which the affinity ligand has binding specificity, as a calibrating agent for calibrating fluorescence-based detection systems, as a tracer (e.g., to trace the flow of a fluid containing the microspheres), and a combination thereof.
Typically, conventional fluorescent dyes (e.g., fluorescein, rhodamine, phycoerythrin, and the like) are used for labeling microspheres. These conventional fluorescent dyes typically have an excitation spectrum that may be quite narrow; hence, it is often difficult to find a wavelength spectrum of light suitable for simultaneously excit- ing several different fluorescent labels (e.g., differing in color of fluorescence emission) . However, even when a single light source is used to provide a excitation wavelength spectrum (in view of the spectral line width) , often there is insufficient spectral spacing between the emission optima of different species (e.g., differing in color) of fluorescent dyes to permit individual and quantitative detection without substantial spectral overlap. Additionally, conventional fluorescent dyes are susceptible to photobleaching which limits the time in which a fluorescent signal can be detected, and limits time-resolved fluorescence (fluorescent signal integration over time) . Additional limitations of fluorescent dyes include fluorescence quenching, and shifts in fluorescence emission spectra, depending on the environment in which dyes are excited. Fluorescent nanocrystals comprising either semiconductor nanocrystals or doped metal oxide nanocrystals have been reported to resist photobleaching, share an excitation wavelength spectrum, and are capable of emitting fluorescence of high quantum yield and with discrete peak emission spectra. However, these nanocrystals lack sufficient solubility in aqueous-based environments required for labeling microspheres; i.e., in aqueous-based environments, the nanocrystals interact together in forming aggregates, which leads to irreversible flocculation of the nanocrystals. Thus, there remains a need for fluorescent microspheres that: (a) may be used in either single color or multicolor analysis; (b) are comprised of fluorescent nanocrystals which are sufficiently soluble in aqueous-based solutions to permit an effective concentration of the fluorescent nano- crystals to be operably bound to polymeric microspheres in forming fluorescent microspheres; (c) which may be excited with a single wavelength spectrum of light resulting in detectable fluorescence of high quantum yield and with discrete peak emission spectra; (d) that are not susceptible to photobleaching and (e) which may further comprise one or more molecules of affinity ligand for use in fluorescence- based detection systems.
SUMMARY OF THE INVENTION
Provided is a fluorescent microsphere comprised of a polymeric microsphere that is labeled with (operably bound to or having embedded in its surface) a plurality of at least one type of fluorescent nanocrystals, such that following excitation of the fluorescent microsphere with an appropriate excitation wavelength spectrum, the fluorescent microsphere will emit fluorescence of high quantum yield and with discrete peak emission. Fluorescent microspheres may differ in size and composition, and can be varied in the intensity of fluorescence emission and the one or more colors of fluorescence emission by changing the amount and type of fluorescent nanocrystals, respectively, in the method of preparing the microspheres. Thus, the fluorescent properties of the fluorescent microspheres, such as inten- sity and color, is sensitive to the corresponding fluorescent nanocrystals used to produce the fluorescent micro- spheres . A resultant advantage of the fluorescent micro- spheres of the present invention is that they may be produced to have a far greater degree of fluorescence (inten- sity) than previously known fluorescent microspheres. Additionally, the fluorescent microspheres may be used for measuring a plurality of analytes in a single sample. For example, a first population of fluorescent microspheres may be (a) labeled with a plurality of one type of fluorescent nanocrystals which will emit a red fluorescent signal upon excitation, and (b) be tagged with affinity ligand having binding specificity for a first analyte. A second population of fluorescent microspheres may be (a) labeled with a plurality of one type of fluorescent nanocrystals which will emit a yellow fluorescent signal upon excitation, and (b) be tagged with affinity ligand having binding specificity for a second analyte. Thus, because the first and second populations of fluorescent microspheres can be excited with a single wavelength spectrum of light resulting in detectable fluorescence of high quantum yield and with discrete peak emission spectra, and because the first and second populations of fluorescent microspheres can bind their respective analyte (via their affinity ligand) , the two populations of fluorescent microspheres can be mixed within one sample in simultaneously measuring for the presence of the first and second analytes .
Advantages of the fluorescent microspheres over individual nanocrystals which have been functionalized to include an affinity ligand, include the following. First, a single nanocrystal may only be functionalized with a limited number of affinity ligands. In contrast, a fluorescent microsphere according to the present invention can be labeled with a far greater number of fluorescent nanocrystals in enabling a fluorescent signal much greater in intensity than a single fluorescent nanocrystal can emit. Such an advantage is particularly useful in measuring an analyte which is present in minute quantities (and hence, can be bound by only a limited number of affinity ligand) . Additionally, more than one type of fluorescent nanocrystal may be used to label the fluorescent microspheres. Hence, the fluorescent microspheres may comprise a plurality of types of fluorescent nanocrystals in encoding the fluorescent microspheres with a specific, identifiable code (based on the emission spectra which can comprise both color and intensity) which can be used to distinguish this population of microspheres from a population of fluorescent microspheres which encoded with a different fluorescence pattern. Such encoded fluorescent microspheres are particularly suited for multi- dimensional microarray formats. Further, in a method of producing the fluorescent microspheres according to the present invention, by controlling the proportion of starting materials (e.g., number of polymeric microspheres, and the number and composition of fluorescent nanocrystals) , precise control may be achieved with respect to the basic fluorescent properties of the resultant fluorescent microspheres . Also provided is a kit comprising the fluorescent micro- spheres, and may further comprise the fluorescent micro- spheres operably bound to affinity ligand.
The above and other objects, features, and advantages of the present invention will be apparent in the following Detailed Description of the Invention when read in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a graph illustrating the relative intensity of an exemplary fluorescent microsphere according to the present invention, as compared to that of a fluorescent nanocrystal. FIG. 2 is a graph illustrating the relative intensity of another exemplary fluorescent microsphere according to the present invention, as compared to that of a fluorescent nanocrystal .
DETAILED DESCRIPTION OF THE INVENTION - -Definitions- -
By the term "analyte" is meant, for the purposes of the specification and claims to refer to a molecule of an organic or inorganic nature, the presence and/or quantity of which is being tested for; and which contains a molecular component (domain or sequence or epitope or portion or chemical group or determinant) for which the affinity ligand has binding specificity. The molecule may include, but is not limited to, a nucleic acid molecule, protein, glyco- protein, eukaryotic or prokaryotic cell, lipoprotein, peptide, carbohydrate, lipid, phospholipid, aminoglycans, chemical messenger, biological receptor, structural component, metabolic product, enzyme, antigen, drug, therapeutic, toxin, inorganic chemical, organic chemical, and the like.
By the term "affinity ligand" is meant, for purposes of the specification and claims, to mean a molecule which has binding specificity and avidity for a molecular component of, or associated with, an analyte. In general, affinity ligands are known to those skilled in the art to include, but are not limited to, lectins or fragments (or derivatives) thereof which retain binding function; monoclonal antibodies ("mAb", including chimeric or genetically modi- fied monoclonal antibodies (e.g., "humanized")); peptides; aptamers; nucleic acid molecules (including, but not limited to, single stranded RNA or single-stranded DNA, or single- stranded nucleic acid hybrids) ; avidin, or streptavidin, or avidin derivatives; and the like. The invention may be practiced using a preferred affinity ligand (e.g., a mAb) to the exclusion of affinity ligands other than the preferred affinity ligand. The term "monoclonal antibody" is also used herein, for purposes of the specification and claims, to include immunoreactive fragments or derivatives derived from a mAb molecule, which fragments or derivatives retain all or a portion of the binding function of the whole mAb molecule. Such immunoreactive fragments or derivatives are known to those skilled in the art to include F(ab')2, Fab', Fab, Fv, scFV, Fd' and Fd fragments. Methods for producing the various fragments or derivatives from mAbs are well known in the art. For example, F(ab')2 an be produced by pepsin digestion of the monoclonal antibody, and Fab' may be produced by reducing the disulfide bridges of F(ab')2 fragments. Fab fragments can be produced by papain digestion of the monoclonal antibody, whereas Fv, single chain antibodies and aptamers can be prepared according to biotechnological methods known in the art. Lectins, and fragments thereof, are commercially available. By the term "fluorescent microsphere" is meant, for purposes of the specification and claims to refer to a polymeric microsphere labeled with a plurality of fluorescent nanocrystals, wherein the fluorescent microsphere comprises a polymeric microsphere having a plurality of fluorescent nanocrystals operably bound thereto, or comprises a polymeric microsphere having embedded in its surface a plurality of fluorescent nanocrystals.
By the term "polymeric microsphere" is meant, for purposes of the specification and claims to refer to a bead which is substantially spherical in shape, and is comprised of a polymeric material which may include, but is not limited to, latex, acrylic, glass/polymer composites, a thermoplastic (e.g., one or more of polystyrenes, polyvinyl chloride, polyacrylate, nylon, substituted styrenes, poly- amides, polycarbonate, polymethylacrylic acids, polyalde- hydes, and the like) , a magnetic material in combination with a polymeric material, and a combination thereof. In one embodiment, the polymeric material may further comprise carbon black in a % weight in a range of from about 0.5 to about 5 with respect to the polymeric material, which may minimize (reduce or quench) intrinsic fluorescence of the polymeric material, if any. For example, the carbon black may be mixed into a solution of a thermoplastic, and then the mixture is plasticized into a solid composite. In a preferred embodiment, the polymeric microspheres may further comprise one or more molecules of affinity ligand operably bound thereto. Methods for operably binding affinity ligand to the surface of polymeric microspheres are well known in the art. Depending on the composition of the polymeric microspheres, typically the microspheres will comprise one or more types of reactive functionalities which react with reactive functionalities of an affinity ligand resulting in affinity ligand being operably bound to the polymeric micro- spheres. In a preferred embodiment, the one or more types of reactive functionalities present on the surface of the polymeric microsphere comprises a plurality of carboxyl- reactive groups, a plurality of amine-reactive groups, or a combination thereof. In a preferred embodiment, the average diameter of the polymeric sphere is in a range of from about 0.05 micron (μm) to about 500 μm; and most preferably, in a range of from about 0.1 μm to about 10 μm. As will be appreciated by those skilled in the art, the composition, shape, size, and density of the polymeric microsphere may vary depending on the factors such as the assay system in which it is used, as well as the nature of an analyte to be detected. A preferred polymeric microsphere may be used to the exclusion of a polymeric microsphere other than the preferred polymeric microsphere . By the term "fluorescent nanocrystals" is meant, for purposes of the specification and claims to refer to nanocrystals comprising semiconductor nanocrystals or doped metal oxide nanocrystals, wherein the nanocrystals are operably bound to, and functionalized by the addition of, a plurality of molecules which provide the functionalized fluorescent nanocrystals with reactive functionalities to enable the fluorescent nanocrystals to become operably bound to the polymeric microspheres in forming the fluorescent microspheres according to the present invention. In a pre- ferred plurality of molecules is selected from the group consisting of carboxylic acid, diaminocarboxylic acid, a monoaminocarboxylic acid, and a combination thereof. A preferred type of molecules may be used to the exclusion of molecules other than the preferred type of molecules. In a preferred embodiment, the functionalized nanocrystals are sufficiently soluble in an aqueous-based environment to permit the fluorescent nanocrystals to label (operably bound to or embedded in) the polymeric microspheres in forming fluorescent microspheres in an aqueous-based environment.
By the term "semiconductor nanocrystals" is meant, for purposes of the specification and claims to refer to quantum dots (crystalline semiconductors) comprised of a core comprised of at least one of a Group II-VI semiconductor material (of which ZnS, and CdSe are illustrative examples) , or a Group III-V semiconductor material (of which GaAs is an illustrative example) , a Group IV semiconductor material, or a combination thereof. In a preferred embodiment, the core of the quantum dots may be passivated with a semiconductor overlayering ("shell") uniformly deposited thereon. For example, a Group II-VI semiconductor core may be passivated with a Group II-VI semiconductor shell (e.g., a ZnS or CdSe core may be passivated with a shell comprised of YZ wherein Y is Cd or Zn, and Z is S, or Se) . As known to those skill- ed in the art, the size of the semiconductor core correlates with the spectral range of emission. Table 1 is an illustrative example for CdSe. Table 1
Figure imgf000010_0001
In a preferred embodiment, the semiconductor nanocrystals are produced using a continuous flow process and system (as disclosed in U.S. Patent No. 6,179,912), and have a particle size that varies by less than +/- 4% in the average particle size. In a preferred embodiment, the semiconductor nanocrys- tals comprise a monodisperse population having an average particle size (as measure by diameter) in the range of approximately 1 nanometer (nm) to approximately 20 nm.
By the term "doped metal oxide nanocrystals" is meant, for purposes of the specification and claims to refer to nanocrystals comprised of: a metal oxide, and a dopant comprised of one or more rare earth elements. For example, suitable metal oxides include, but are not limited to, yttrium oxide (Y203) , zirconium oxide (Zr02) , zinc oxide (ZnO) , copper oxide (CuO or Cu20) , gadolinium oxide (Gd203) , praseodymium oxide (Pr203) , lanthanum oxide (La203) , and alloys thereof. The rare earth element comprises an element selected from the Lanthanide series and includes, but is not limited to, europium (Eu) , cerium (Ce) , neodymium (Nd) , samarium (Sm) , terbium (Tb) , gadolinium (Gd) , holmium (Ho) , thulium (Tm) , an oxide thereof, and a combination thereof. As known to those skilled in the art, depending on the dopant, an energized doped metal oxide nanocrystal is capable of emitting light of a particular color. Thus, the nature of the rare earth or rare earths are selected in consequence to the color sought to be imparted (emitted) by a doped metal oxide nanocrystal used to label a microsphere according to the present invention. A given rare earth or rare earth combination has a given color, thereby permitting the provision of doped metal oxide nanocrystals, each of which may emit (with a narrow emission peak) a color over an entire range of colors by adjusting the nature of the dopant, the concentration of the dopant, or a combination thereof. For example, the emission color and brightness (e.g., intensity) of a doped metal oxide nanocrystal compri- sing Y203:Eu may depend on the concentration of Eu; e.g., emission color may shift from yellow to red with increasing Eu concentration. For purposes of illustration only, representative colors which may be provided are listed in Table 2. Table 2
Figure imgf000012_0001
Methods for making doped metal oxide nanocrystals are known to include, but are not limited to a sol-gel process, and an organometallic reaction. As will be apparent to one skilled in the art, the dopant (e.g., one or more rare earth elements) are incorporated into the doped metal oxide nanocrystal in a sufficient amount to permit the doped metal oxide nanocrystal to be put to practical use in fluorescence detection as described herein in more detail. An insufficient amount comprises either too little dopant which would fail to emit sufficient detectable fluorescence, or too much dopant which would cause reduced fluorescence due to concentration quenching. In a preferred embodiment, the amount of dopant in a doped metal oxide nanocrystal is a molar amount in the doped metal oxide nanocrystal selected in the range of from about 0.1% to about 25%. Doped metal oxide nanocrystals may can be excited with a single excitation light source resulting in a detectable fluorescence emission of high quantum yield (e.g., a single quantum dot having at a fluorescence intensity that may be a log or more greater than that a molecule of a conventional fluorescent dye) and with a discrete fluorescence peak. Typically, they have a substantially uniform size of less than 200 Angstroms, and preferably have a substantially uniform size in the range of sizes of from about 1 nm to about 5 nm, or less than 1 nm. In a preferred embodiment, the doped metal oxide nanocrystals are comprised of metal oxides doped with one or more rare earth elements, wherein the dopant comprising the rare earth element is capable of being excited (e.g., with ultraviolet light) to produce a narrow spectrum of fluorescence emission. In another preferred embodiment, the doped metal oxide has both fluorescent properties (when excited with an excitation light source) and magnetic properties; thus, a polymeric microsphere (which is substantially nonmagnetic) operably bound to a plurality of fluorescent nanocrystals (comprising doped metal oxide nanocrystals which are magnetic material) may form fluorescent microspheres according to the present invention which are magnetic.
By the term "operably bound" is meant, for purposes of the specification and claims to refer to fusion or bond or an association of sufficient stability to withstand conditions encountered in a method of detection, between a combi- nation of different molecules such as, but not limited to, between the functionalized nanocrystal and the polymeric microsphere, between a fluorescent nanocrystal and the molecules by which they are functionalized (e.g., carboxylic acid, diaminocarboxylic acid, or a monoaminocarboxylic acid), and a combination thereof. As known to those skilled in the art, the bond may comprise one or more of covalent, ionic, hydrogen, van der Waals, and the like. As known to those skilled in the art, and as will be more apparent by the following embodiments, there are several methods and compositions in which two or more molecules may be operably bound utilizing reactive functionalities. Reactive functionalities include, but are not limited to, free chemical groups (e.g., thiol, or carboxyl, hydroxyl, amino, amine, sulfo, etc.), and reactive chemical groups (reactive with free chemical groups) .
The term "suitable conditions" is used herein, for purposes of the specification and claims, and with reference to a process of reacting two components (e.g., polymeric microsphere and fluorescent nanocrystals; fluorescent microsphere comprising affinity ligand and an analyte for which the affinity ligand has binding specificity) , to mean those conditions under which the components may become operably bound to each other. As known to those skilled in the art, such conditions may include one or more of: a pH range of from about 3 to about 9, ionic strengths such as that ranging from distilled water to about 1 molar sodium chloride, and a temperature in the range of from about 4°C to about 45°C; and may further include a time sufficient for binding to occur (e.g., in a range of from about 10 minutes to about 2 hours) .
By the term "diaminocarboxylic acid" is meant, for purposes of the specification and claims to refer to an amino acid that has two free amine groups. The amino acid may be a naturally occurring amino acid, a synthetic amino acid, a modified amino acid, an amino acid derivative, and an amino acid precursor (e.g., citrulline and ornithine are intermediates in the synthesis of arginine) . In a preferred embodiment, the diaminocarboxylic acid contains neutral
(uncharged) polar functional groups which can hydrogen bond with water, thereby making the diaminocarboxylic acid (and the quantum dot to which it is made a part of) relatively more soluble in aqueous solutions containing water than those with nonpolar functional groups. Exemplary diaminocarboxylic acids include, but are not limited to, lysine, asparagine, glutamine, arginine, citrulline, ornithine, 5- hydroxylysine, djenkolic acid, β-cyanoalanine, and synthetic diaminocarboxylic acids such as 3 , 4-diaminobenzoic acid, 2, 3-diaminopropionic acid, 2, 4-diaminobutyric acid, 2,5- diaminopentanoic acid, and 2, 6-diaminopimelic acid.
By the term "amino acid" is meant, for purposes of the specification and claims to refer to a molecule that has at least one free amine group and at least one free carboxyl group. The amino acid may have more than one free amine group, or more than one free carboxyl group, or may further comprise one or more free chemical reactive groups other than an amine or a carboxyl group (e.g., a hydroxyl, a sulf- hydryl, etc.) . The amino acid may be a naturally occurring amino acid, a synthetic amino acid, a modified amino acid, an amino acid derivative, and an amino acid precursor. The amino acid may further be selected from the group consisting of a monoaminocarboxylic acid, and a diaminocarboxylic acid. In a preferred embodiment, the monoaminocarboxylic acid contains one or more neutral (uncharged) polar functional groups which can hydrogen bond with water, thereby making the monoaminocarboxylic acid (and the quantum dot to which it is made a part of) relatively more soluble in aqueous solutions containing water than those with non-polar functional groups. Exemplary monoaminocarboxylic acids include, but are not limited to, glycine, serine, threonine, cysteine, β-alanine, homoserine, γ-aminobutyric acid, and homocysteine . By the term "carboxylic acid" is meant, for purposes of the specification and claims to refer to a compound having the formula HS(CH2)nX, wherein X is a carboxylate (carboxylic moiety) . "n" is a number in the range of from 1 to about 20, and preferably greater than 4. In a preferred embodi- ment, the thiol group of the carboxylic acid can be used as a reactive functionality for the carboxylic acid to become operably bound to the nanocrystal, depending on the composition of the nanocrystal (e.g., to Cd, Zn and the like) . Additionally, the carboxylic moiety of the carboxylic acid imparts water solubility to the nanocrystals. Exemplary carboxylic acids may include, but are not limited to, mercaptocarboxylic acid, or mercaptofunctionalized amines (e.g., aminoethanethiol-HCl, or 1-amino- -methyl-2- propanethiol-HCl) .
The following examples are illustrative of the methods and fluorescent microspheres of the present invention.
EXAMPLE 1
Fluorescent nanocrystals comprise nanocrystals which have been functionalized by the addition of a plurality of molecules; and preferably, the molecules are selected from an amino acid, a carboxylic acid, and a combination thereof. For example, the nanocrystals may comprise semiconductor nanocrystals that have a core selected from the group consisting of CdSe, CdS, and CdTe (collectively referred to as "CdX"), and may further comprise a passivating shell comprised of YZ wherein Y is Cd or Zn, and Z is S, or Se. Typically, CdX core/YZ shell quantum dots are overcoated with trialkylphosphine oxide, with the alkyl groups most commonly used being butyl and octyl . In one preferred embodiment, the CdX cor/YZ shell quantum dots are treated with a large excess of mercaptocarboxylic acid in exchanging the trialkylphosphine oxide coat with a coat comprising a plurality of carboxylic acid molecules. For example, (CdSe) ZnS nanocrystals were prepared in a pyridine solution. The pyridine overcoating of the (CdX) core/YZ shell nanocrystals were exchanged with a carboxylic acid comprising mercaptocarboxylic acid. Exchange of the coating group is accomplished by treating the water-insoluble, pyridine- capped quantum dots with a large excess of neat mercaptocarboxylic acid. To accomplish this, the pyridine-capped (CdSe) ZnS quantum dots were precipitated with hexanes, and then isolated by centrifugation. The residue was dissolved in neat mercaptoacetic acid, with a few drops of pyridine added, if necessary, to form a transparent solution. Chloroform was added to precipitate the nanocrystals and wash away excess thiol. The nanocrystals were isolated by centrifugation, washed once more with chloroform, and then washed with hexanes . The residue was briefly dried with a stream of argon. The resultant nanocrystals, coated with molecules of carboxylic acid, were then soluble in water or other aqueous solutions. The nanocrystals, in an aqueous solution, were centrifuged once more, filtered through a 0.2 μm filter, degassed with argon, and stored in an amber vial. The nanocrystals may then be further functionalized by amino acid comprising a diaminocarboxylic acid. The diaminocar- boxylic acid molecules were operably bound to the carboxylic acid molecules of the nanocrystals by using commercially available crosslinking agents and methods known to those skilled in the art. For example, the carboxylic acid-coated nanocrystals were dissolved in an aqueous buffer system (pH of about 7) . To the nanocrystals was added EDC (l-ethyl-3-
[3-dimethylaminopropyl] carbodiimide) and sulfoNHS (sulfo-N- hydroxysuccinimide) in 500-1000 times excess. The resulting solution was stirred at room temperature for 30 minutes. Mercaptoethanol was added to neutralize unreacted EDC at 20 mM concentration and stirred for 15 minutes. The entire solution was then added drop-wise, with stirring, to a solution of a diaminocarboxylic acid comprising lysine (large excess) in the same buffer; and the mixture was stirred for 2 hours at room temperature. Ethanolamine (30 mM) was added to quench the reaction; and the mixture was stirred for 30 minutes at room temperature or left overnight at 4°C. The solution was centrifuged to remove any precipitated solids, and then ultrafiltered through a 30kD MW centrifugal filter. The resultant concentrated, fluorescent nanocrystals can be solubilized in an aqueous solution of choice. Once solu- bilized, the resulting solution can be stored in an amber vial under an inert gas to prevent flocculation. The fluorescent nanocrystals may be operably bound to a suc- cessive layer of amino acid molecules by, for example, repeating the procedure and reaction using EDC and sulfoNHS with the amino acid molecules comprising the successive layer.
Similarly, a nanocrystal comprising a doped metal oxide nanocrystal may be operably bound to a plurality of molecules (e.g., a carboxylic acid, and amino acid, or a combination thereof) using methods known in the art. For example, the plurality of molecules having reactive functionalities comprising free carboxyl groups can be chemi- sorbed, adsorbed or otherwise permanently added to the metal oxide portion of the nanocrystal. For example, the metal oxide nanocrystals are suspended in an aqueous solution of an amino acid comprising homocysteine having a pH of about 3.5 for about an hour. The reaction is then stopped by adjusting the pH to neutral, and dialyzing out the aqueous solution.
As an alternative, fluorescent nanocrystals functionalized with a plurality of homocysteine molecules were prepared as follows. Nanocrystals (e.g., (CdSe)ZnS) coated with an organic layer (e.g., mercaptoacetic acid) were treated with a molar excess of homocysteine in replacing the organic layer with a coating comprising a plurality of homocysteine molecules . The approximate number of surface Zn sites on the specific size of nanocrystals utilized was calculated. At least a 5 times molar excess of homocysteine (as compared to the number of surface Zn sites) was added to the nanocrystals, as per the following formula. Grams homocysteine = 5 (number of Zn surface sites) (volume of solution containing the nanocrystals) (concentration of nanocrystals in solution) (135.2) .
The mixture was stirred to dissolve the homocysteine, and then stored at 4°C for 24 hours. The resultant solution was then centrifuged to remove any precipitate, and the supernatant was transferred to a centrifugal filter for the appropriate volume of supernatant (preferably, with a molecular weight cutoff of about 10 kD or below to retain the fluorescent nanocrystals coated with homocysteine) . After centrifugation, and when the desired minimum volume is reached, the fluorescent nanocrystals were then rediluted in the appropriate aqueous solution (e.g., HEPES buffer) to a volume in which the original mass of homocysteine had been dissolved. The steps of filtering and redilution of the fluorescent nanocrystals in solution may be repeated to improve purity. The resultant fluorescent nanocrystals comprising homocysteine-coated nanocrystals may then be degassed by bubbling with an inert gas, and then stored at
4°C in an amber bottle.
EXAMPLE 2 This example illustrates one embodiment of fluorescent microspheres, and a method of making the fluorescent micro- spheres, according to the present invention. In this example, polymeric microspheres are labeled with fluorescent nanocrystals by contacting the polymeric microspheres with fluorescent nanocrystals under suitable conditions for the fluorescent nanocrystals to become operably bound to the polymeric microspheres in forming fluorescent microspheres . In a preferred embodiment, each polymeric microsphere comprises multiple molecules of reactive functionality comprising a free chemical group, and the fluorescent nanocrystals comprise multiple molecules of reactive functionality comprising reactive chemical groups which are capable of becoming operably bound to the reactive functionality of the polymeric microsphere under suitable conditions so that a plurality of fluorescent nanocrystals become operably bound to a polymeric microsphere in forming a fluorescent micro- sphere. For example, the polymeric microspheres comprise a reactive functionality comprising an amino group, and the fluorescent nanocrystals comprise a reactive functionality comprising an amino-reactive group (e.g., carboxyl or amine) . In another illustrative example, the polymeric microspheres comprise a reactive functionality comprising a thiol group and the fluorescent nanocrystals comprise a reactive functionality comprising a thiol-reactive group (e.g., amine group) .
The polymeric microsphere used in this illustration comprised amine-activated polystyrene-based beads of a size of about 8.8 μm. More particularly, their composition comprised 25% styrene, 55% divinylbenzene, 20% glycidylmeth- acrylate, which was activated with ethylenediamine. Approximately 2.7 x 10s polymeric microspheres (in a volume of 100 μl aqueous solution) was mixed with 10 μl of a 10 μM fluorescent nanocrystal solution, and the mixture was gently agitated at room temperature for 20 minutes. The resultant fluorescent microspheres formed were then collected by centrifugation (e.g., 2 minutes at 2000 x g) , washed with an aqueous solution, and then collected by centrifugation again. To confirm the formation of fluorescent micro- spheres, the resultant microspheres were suspended in a non- aqueous medium (e.g., dimethylsulfoxide, or mineral oil, or heptane) and placed onto a slide for viewing under a fluorescence microscope. Alternatively, the solution containing the resultant microspheres was dried onto a slide for viewing under a fluorescence microscope. The results in Table 3 are illustrative of the fluorescence emitted by fluorescent microspheres according to the present invention. Type 1 fluorescent microspheres comprise fluorescent nanocrystals (homocysteine-coated (CdSe) ZnS) operably bound to amine- activated polymeric microspheres; type 2 fluorescent micro- spheres comprise fluorescent nanocrystals (homocysteine- coated (CdSe) ZnS; different in size than type 1) operably bound to amine-activated polymeric microspheres; type 3 fluorescent microspheres comprise fluorescent nanocrystals (mercaptocarboxylic acid-coated (CdSe) ZnS) operably bound to amine-activated polymeric microspheres; type 4 fluorescent microspheres comprise fluorescent nanocrystals ((CdSe) ZnS nanocrystals comprising a first coat comprising mercaptocarboxylic acid, and a second coat comprising diaminocar- boxylic acid) operably bound to amine-activated polymeric microspheres; and a control comprising polymeric micro- spheres alone. In the fluorescence analyses, the excitation spectrum was from about 360 to about 380 nm. The resultant respective emission, as described by the color observed using the fluorescence microscope and the approximate peak emission wavelength, is listed for each of the type of microsphere .
Table 3
Figure imgf000021_0001
To further illustrate the attendant advantages of the fluorescent microspheres according to the present invention, FIG. 1 illustrates the relative intensity over time after excitation (arrow) of an exemplary fluorescent microsphere as compared to that of a comparative fluorescent nanocrystal used in producing a fluorescent microsphere.
EXAMPLE 3
This example illustrates embodiments of fluorescent microspheres, and a method of making the fluorescent micro- spheres, according to the present invention; wherein polymeric microspheres are labeled with fluorescent nanocrystals by contacting the polymeric microspheres with fluorescent nanocrystals under suitable conditions for the fluorescent nanocrystals to become embedded into the polymeric micro- spheres in forming fluorescent microspheres. In a process of making these fluorescent microspheres, the polymeric microspheres are first exposed to conditions suitable for swelling them in size (e.g., also referred to as "expanded") so as to increase porosity in allowing fluorescent nanocrystals, present in the reaction process, to enter into pores at the surface of each swollen polymeric microsphere. The polymeric microspheres are then exposed to suitable conditions in which the polymeric microspheres become unswollen, thereby physically entrapping the fluorescent nanocrystals in the pores of the polymeric microspheres. Thus, by this process, the fluorescent nanocrystals become embedded in the surface of a polymeric microsphere.
In one embodiment of this example, the polymeric micro- spheres are swelled by exposing them to a temperature sufficient to soften the polymer composition of the polymeric microspheres, but below the melting point of the polymer composition. The suitable conditions may further comprise pressurizing the polymeric microspheres (e.g., to a pressure above atmospheric pressure) which can be used to shorten the time in which to heat the polymeric microspheres to make them swell. Suitable conditions for swelling polymeric microspheres to physically entrap fluorescent nanocrystals can be determined using methods customary in the art. As will be apparent to those skilled in the art, the time and temperature used to swell the polymeric microspheres will depend on the nature (e.g., composition) of the polymeric microspheres. For example, it is generally known that polymeric microspheres comprised of polystyrene can be softened at temperatures in the range of from about 200°C to about 250 °C for a time of about 0.5 to about 10 hours (depending on the type of polystyrene) . Likewise, the amount of superatmospheric pressure to which the polymeric microspheres may be exposed will depend on the temperature of heating, and the nature (e.g., composition) of the polymeric microspheres. For example, to form fluorescent micro- spheres, the polymeric microspheres capable of being swelled to increase porosity are added to a solution containing the fluorescent nanocrystals, wherein the resultant reaction suspension is contained within a reaction vessel. The reaction suspension in the reaction vessel is then subjected to suitable conditions (e.g., heat, or heat and pressuriza- tion) to effect swelling of the polymeric microspheres and entry of the fluorescent nanocrystals into the pores of the swelled polymeric microspheres. The reaction is stopped (e.g., allow the suspension to cool to ambient temperature; or cooling with venting to reduce pressure to atmospheric) resulting in the unswelling of the polymeric microspheres, and the physical entrapment of fluorescent nanocrystals in forming fluorescent microspheres having a uniform distribution of fluorescent nanocrystals embedded therein. The process may further comprise purifying the fluorescent microspheres from any free fluorescent nanocrystals in the reaction suspension (e.g., by one or more of: size such as by centrifugation, size exclusion chromatography, and the like; by affinity chromatography if the fluorescent micro- spheres further comprise affinity ligand) . It will be apparent to one skilled in the art that the ratio of fluorescent nanocrystals to polymeric microspheres may vary with factors which include, but are not limited to, the size of the polymeric microspheres, the desired fluorescent intensity of the resultant fluorescent microspheres, and the like. Preferably, the fluorescent nanocrystals are in a sufficient amount to saturate the surface of each polymeric microsphere present in the reaction. While not intended to be limiting, generally the amount of fluorescent nanocrystals in the reaction is less than or equal to about 20% by weight of the polymeric microspheres in the reaction.
In another embodiment, the polymeric microspheres are swelled by exposing them to an organic medium comprising one or more organic solvents which are able to swell the polymeric microspheres. The degree of swelling necessary for physically entrapping the fluorescent nanocrystals in the polymeric microspheres can be adjusted by the type and amount of solvent using customary methods. As will be apparent to those skilled in the art, the time of exposure to, and concentration of, the one or more solvents used to swell the polymeric microspheres will depend on the nature of the composition of the polymeric microspheres, and the composition of the organic medium used. For example, it is generally known that a wide variety of common liquid organic solvents can be used to swell polymeric microspheres in a controlled manner so as not to permanently damage the polymeric microspheres themselves. Useful solvents may include, but are not limited to, dimethyl sulfoxide (DMSO) , dimethyl- formamide (DMF) , toluene, tetrahydrofuran, chloroform, methylene chloride, acetones, acetonitrile, alcohols, or a combination thereof. In one preferred embodiment, the organic medium is water-miscible. In another preferred embodiment, the organic medium is in a concentration of 30% or more (v/v) for performing the swelling. For example, to form fluorescent microspheres, the polymeric microspheres capable of being swelled to increase porosity are added to organic medium comprising the one or more solvents, and also containing the fluorescent nanocrystals, wherein the resultant reaction suspension is contained within a reaction vessel for a sufficient time to effect the swelling of the polymeric microspheres. The reaction is stopped (e.g., by removing the organic medium from contacting the polymeric microspheres) resulting in unswelling of the polymeric microspheres, and the physical entrapment of fluorescent nanocrystals in forming fluorescent microspheres having a uniform distribution of fluorescent nanocrystals embedded therein. The process may further comprise purifying the fluorescent microspheres from any free fluorescent nanocrystals in the reaction suspension (e.g., by one or more of: size such as by centrifugation, size exclusion chromatography, and the like; by affinity chromatography if the fluorescent microspheres further comprise affinity ligand) . While not intending to be limiting, and in a preferred embodiment, generally the reaction is carried out at a temperature in the range of from about 5°C to about 30°C during a sufficient period of time for the organic medium to diffuse or absorb into the polymeric microspheres to cause their swelling. It will be apparent to one skilled in the art that the ratio of fluorescent nanocrystals to polymeric microspheres may vary with factors which include, but are not limited to, the size of the polymeric microspheres, the desired fluorescent intensity of the resultant fluorescent microspheres, and the like. Preferably, the fluorescent nanocrystals are in a sufficient amount to saturate the surface of each polymeric microsphere present in the reaction. While not intended to be limiting, generally the amount of fluorescent nanocrystals in the reaction is less than or equal to about 20% by weight of the polymeric microspheres in the reaction.
In a preferred embodiment, the swellable polymeric microspheres (and the resultant fluorescent microspheres) further comprise multiple molecules of reactive functionality comprising a free chemical group which may include, but is not limited to, carboxyl, amine, amide, tiol, ester, sulfhydryl, and the like. The surface reactive functionalities of a fluorescent microsphere may be used as a means for operably binding affinity ligand to the fluorescent microsphere, wherein the affinity ligand has a free chemical group which is reactive (in forming a bond) with the surface reactive functionalities of the microsphere. For example, using conventional chemistry, affinity ligand that may be operably bound to the surface of the fluorescent micro- spheres may include, but are not limited to, antibody, avidin, biotin, protein A or G, lectin, aptamer, a nucleic acid molecule (e.g., RNA, DNA, hybrids, single stranded, double stranded, synthetic, oligonucleotides, etc.), a carbohydrate chain, a protein with binding specificity for an analyte, and the like. The fluorescent microspheres that further comprise affinity ligand are then used as a detection reagent in an assay for determining the presence or absence of an analyte for which the affinity ligand has binding specificity, as is disclosed herein in more detail. This example illustrates an embodiment of the fluorescent microspheres according to the present invention, as well as a process for making the fluorescent microspheres. The polymeric microspheres used in this illustration comprised amine-activated polystyrene-based beads of a size of about 7.3 μm. More particularly, their composition comprised 70% methylmethacrylate, 20% glycidylmethacrylate, and 10% ethylene glycol dimethacrylate. A 10% (w/w) suspension of the polymeric microspheres (in a volume of 10 μl) was diluted in a reaction vessel with an organic medium comprised of either of two solvents, DMSO or DMF (90 μl) . To each was added 10 μl of a 10 μM fluorescent nanocrystal solution (in an aqueous buffer; e.g., HEPES), and the resultant reaction suspension was mixed and incubated at room temperature for a sufficient time for swelling of the polymeric microspheres. Although a sufficient time may comprise only minutes, in this case the reaction was allowed to proceed for a time that ranged from about 1 hour to about 24 hours. The reactions were stopped by adding to the respective reaction suspension a water-based buffer or water, and then removing the solvent. In this case, to each reaction suspension was added, and mixed with, 1 ml of HEPES buffer, followed by pelleting the resultant fluorescent microspheres by centrifugation (e.g., 2 minutes at 2000 x g) . Each preparation of fluorescent microspheres was washed again with the buffer, and then collected by centrifugation. Each of the preparations of fluorescent microspheres was then resuspended in 20 μl of buffer. To confirm the formation of fluorescent microspheres, a 10 μl of each of the preparations of fluorescent micro- spheres was suspended in a non-aqueous medium (e.g., formalin solution (4% formaldehyde) , dimethylsulfoxide, or mineral oil) and placed onto a microscopic slide for viewing under a fluorescence microscope. After excitation with ultraviolet light, and using a 425 nm long pass emission filter, each of the preparation of fluorescent microspheres was observed under fluorescent microscopy as being a strong red fluorescence (614 nm) , characteristic of the fluorescent nanocrystals (homocysteine-coated (CdSe) ZnS) embedded in the fluorescent microspheres. To further illustrate an attendant advantage of the fluorescent microspheres according to the present invention, FIG. 2 illustrates the relative intensity of an exemplary fluorescent microspheres ("FM") compared to that of comparative fluorescent nanocrystals ("NC") used in producing the fluorescent microspheres, expressed as a ratio of FM:NC, and with respect to concen- tration of analyte ("antigen"). As previously described herein, in a detection assay the intensity of the fluorescent microspheres having affinity ligand bound thereto significantly increases, compared to comparative functionalized nanocrystals having affinity ligand bound thereto, as the concentration of analyte (for which the affinity ligand has binding specificity) decreases.
EXAMPLE 4 This example illustrates another embodiment of fluores- cent microspheres, and a method of making the fluorescent microspheres, according to the present invention; wherein polymeric microspheres are contacted with fluorescent nanocrystals under suitable conditions for forming fluorescent microspheres, and wherein the fluorescent microspheres fur- ther comprise a plurality of molecules of affinity ligand which are contacted with the fluorescent microspheres under suitable conditions for the affinity ligand to be operably bound to the fluorescent microspheres. In one preferred embodiment of the present invention, the polymeric micro- spheres have affinity ligand operably bound thereto before fluorescent nanocrystals are operably bound to the polymeric microspheres in producing fluorescent microspheres according to the present invention. In another preferred embodiment, fluorescent microspheres are produced first (e.g., by opera- bly binding the fluorescent nanocrystals to, or embedding the fluorescent nanocrystals in, the polymeric micro- spheres) , and then the affinity ligand is operably bound to the fluorescent microspheres. In illustrating this latter preferred embodiment, fluorescent microspheres were made according to the methods described in Example 2 herein. To approximately 1.4 x 107 fluorescent microspheres (in a volume of 500 μl aqueous solution) was added 2 mg of EDC (in 100 μl aqueous solution) and 5 mg sulfo-NHS (in 100 μl aqueous solution), and the mixture was mixed for 10 minutes. Mer- captoethanol (1 μl) was added to the mixture with stirring for 5 minutes. Affinity ligand (in this illustrative embodiment, neutravidin; 10 μg) was added to the mixture with stirring for 1 hour. TRIS (30mM) was then added to the mixture with stirring for 30 minutes. The resultant fluorescent microspheres were then pelleted by centrifugation, were washed several times in aqueous solution to wash away free neutravidin, and then resuspended in an aqueous solution. The following example illustrates (a) a test that neutravidin was operably bound to the fluorescent micro- spheres; and (b) a method of using the fluorescent micro- spheres to detect an analyte in a sample. Approximately 1.4 x 106 fluorescent microspheres in 10 μl of aqueous solution was mixed and incubated with approximately 3 x 105 biotiny- lated polystyrene beads (6.7 μm in diameter) for 30 minutes at room temperature. The mixture comprising fluorescent microspheres and polystyrene beads was washed with aqueous solution and vigorously mixed to break up any clumping do to non-specific aggregation. The microspheres and beads were centrifuged, resuspended in DMSO, mixed again, and then mounted on a microscope slide with a coverslip. The slide was then examined under bright-field and fluorescence microscopy. The analysis showed that nearly all biotinylated polystyrene beads were bound to fluorescent microspheres.
The observed binding included large aggregates of beads and microspheres together. Few instances of non-specific aggregation were observed. As an additional test that neutravidin was operably bound to the fluorescent microspheres, a dot blot was performed in a microfuge tube. Approximately 1.4 x 106 fluorescent microspheres were placed in a 1.5 ml microfuge tube. Added to the tube was a blocking solution (1% dry non-fat milk, 0.05% detergent, in buffer) for an incubation of 1 hour. The fluorescent microspheres were then pelleted by centrifugation. The fluorescent microspheres were then resuspended in 1 μg/ml biotin-labeled rabbit anti-mouse IgG in blocking solution, incubated for one hour, and then followed by several cycles of pelleting and washing. The fluorescent microspheres were then resuspended in 1 μg/ml horseradish peroxidase-labeled goat anti-rabbit-IgG in blocking solution, incubated for one hour, and then followed by several cycles of pelleting and washing. The fluorescent microspheres were then resuspended in a color development reagent (DAB) for 15 minutes, and then washed to remove excess color development solution. By visual examination, the fluorescent microspheres were strongly stained dark brown, indicating that neutravidin was operably bound to the surface of the fluorescent microspheres .
In another example of fluorescent microspheres and a method of making the fluorescent microspheres according to the present invention, the polymeric microspheres are swell- ed and unswelled under suitable conditions so as to physically entrap fluorescent nanocrystals in forming fluorescent microspheres, and wherein the fluorescent microspheres further comprise a plurality of molecules of affinity ligand which are contacted with the fluorescent microspheres under suitable conditions for affinity ligand to be operably bound to the fluorescent microspheres. In one preferred embodiment of the present invention, the fluorescent microspheres are formed first, and then affinity ligand is operaly bound thereto in producing fluorescent microspheres further com- prising affinity ligand according to the present invention. In illustrating this preferred embodiment, fluorescent microspheres are made according to one of the methods described in Example 3 herein. To approximately 1.4 x 107 fluorescent microspheres (in a volume of 500 μl aqueous solution) is added 2 mg of EDC (in 100 μl aqueous solution) and 5 mg sulfo-NHS (in 100 μl aqueous solution) , and the mixture is mixed for 10 minutes. Mercaptoethanol (1 μl) is added to the mixture with stirring for 5 minutes. Affinity ligand (in this illustrative embodiment, neutravidin; 10 μg) is added to the mixture with stirring for 1 hour. TRIS (30mM) is then added to the mixture with stirring for 30 minutes . The resultant fluorescent microspheres are then pelleted by centrifugation, washed several times in aqueous solution to wash away free neutravidin, and then resuspended in an aqueous solution.
These illustrative examples show that affinity ligand may be operably bound to fluorescent microspheres while retaining the ability of the bound affinity ligand to interact with analyte for which it has binding specificity.
EXAMPLE 6 This example illustrates another embodiment of fluorescent microspheres according to the present invention, and further illustrates a method of making the fluorescent microspheres according to the present invention. In this illustrative embodiment the fluorescent microspheres comprised fluorescent nanocrystals which label (operably bound to or embedded in the surface of) polymeric microspheres comprising a magnetic responsive material ("magnetic material") with a polymeric, nonmagnetic coating. Such polymeric microspheres are known to include general characteristics as follows. First, magnetic materials useful for the microspheres may include, but are not limited to, ferromagnetic, ferrimagnetic, paramagnetic, superparamagnetic materials, and the like. Such magnetic materials may include, but are not limited to: metals, such as nickel, iron, cobalt, chromium, manganese, and the like; lanthanide series elements, such as neodymium, erbium, and the like; alloys such as magnetic alloys of metals; metal oxides, such as ferric oxide, chromium oxide, nickel oxide, and the like; composites, such as ferrites, magnetite, and the like; and combinations thereof. As will be appreciated by those skilled in the art, the diameter of a core of magnetic material core may vary widely depending on the size of the polymeric microsphere of which it is a part; the composition, shape, size and density of the magnetic material; and the assay protocol in which the polymeric microsphere is used. In a preferred embodiment, the diameter of a magnetic material core is a size in the range of from about 0.01 μm to about 10 μm. Polymeric materials into which may be embedded the magnetic material, or with which may be used to coat a magnetic material core, have been previously described herein in more detail. As known to those skilled in the art, the polymeric microspheres comprising magnetic material may comprise: a magnetic material core and a polymeric, nonmagnetic coating; a nonmagnetic core (e.g., polymeric or other nonmagnetic material) with a magnetic material layer thereon, and a polymeric, nonmagnetic coating; a magnetic material embedded within a polymeric, nonmagnetic material; and a magnetic material dispersed within a polymeric, nonmagnetic material (such as may be obtained by mixing the magnetic material into a solution of a thermoplastic, and then plasticizing the mixture into a solid composite) .
In this illustrative example, the commercially-obtained polymeric microspheres comprised polymer-coated magnetite which were also coated with affinity ligand (either strept- avidin (2.8μm diameter), or goat anti-mouse I G (4.5 μm diameter) on the surface of the microspheres. Thus, this example is also illustrative of an embodiment according to the present invention wherein polymeric microspheres compri- sing affinity ligand operably bound thereto, are then contacted with fluorescent nanocrystals under suitable conditions for the fluorescent nanocrystals to become operably bound thereto. Approximately 6.7 x 107 polymeric micro- spheres (in a volume of 100 μl aqueous solution) was mixed with 100 μl of a 10 μM fluorescent nanocrystal solution, and the mixture was gently agitated at room temperature for 60 minutes . The resultant fluorescent microspheres formed were then collected by centrifugation (e.g., 2 minutes at 2000 x g) , washed with an aqueous solution, and then collected by centrifugation again. To confirm the formation of fluorescent microspheres, the resultant microspheres were suspended in a non-aqueous medium, and placed onto a slide for viewing by fluorescence microscopy. The results in Table 4 are illustrative of the fluorescence emitted by fluorescent microspheres according to the present invention. Fluorescent microspheres comprise fluorescent nanocrystals (e.g., homocysteine-coated (CdSe) ZnS) operably bound to the magnetic polymeric microspheres having streptavidin operably bound thereto ("type A"); fluorescent microspheres comprise fluorescent nanocrystals (e.g., homocysteine-coated (CdSe) ZnS; different in size than type A) operably bound to magnetic polymeric microspheres having streptavidin operably bound thereto ("type B"); fluorescent microspheres comprise fluorescent nanocrystals (e.g., mercaptocarboxylic acid- coated (CdSe) ZnS) operably bound to magnetic polymeric microspheres having streptavidin operably bound thereto
("type C" ) ; fluorescent microspheres comprise fluorescent nanocrystals (e.g., (CdSe) ZnS nanocrystals comprising a first coat comprising mercaptocarboxylic acid, and a second coat comprising diaminocarboxylic acid) operably bound to magnetic polymeric microspheres having streptavidin operably bound thereto ("type D"); a control "A" comprising only polymeric microspheres having streptavidin operably bound thereto; fluorescent microspheres comprise fluorescent nanocrystals (e.g., mercaptocarboxylic acid-coated (CdSe) ZnS) operably bound to magnetic polymeric microspheres having antibody (IgG) operably bound thereto ("type E" ) ; fluorescent microspheres comprise fluorescent nanocrystals (e.g., (CdSe) nS nanocrystals comprising a first coat comprising mercaptocarboxylic acid, and a second coat comprising diaminocarboxylic acid) operably bound to magnetic polymeric microspheres having antibody operably bound thereto ("type F" ) ; and a control "B" comprising only polymeric microspheres having antibody operably bound thereto. In the fluorescence analysis, the excitation spectrum was from about 360 to about 380 nm. The resultant respective emission, as described by the color observed using the fluorescence microscope is listed for each type of microsphere.
Table 4
Figure imgf000034_0001
The following example illustrates (a) a test that affinity ligand of the polymeric microspheres was still functional (e.g., could bind to analyte for which it has binding specificity) after fluorescent nanocrystals were operably bound to the polymeric microspheres in forming fluorescent microspheres according to the present invention; and (b) a method of using the fluorescent microspheres to detect an analyte in a sample. Approximately 1.4 x 10s fluorescent microspheres (as produced according to this Example; and comprising streptavidin as affinity ligand) in 10 μl of aqueous solution was mixed and incubated with approximately 6 x 10s biotinylated polystyrene beads (6.7 μm in diameter) for 30 minutes at room temperature. The mixture comprising fluorescent microspheres and polystyrene beads was washed with aqueous solution and vigorously mixed to break up any clumping do to non-specific aggregation. The microspheres and beads were centrifuged, resuspended in DMSO, mixed again, and then mounted on a microscope slide with a coverslip. The slide was then examined under bright- field and fluorescence microscopy. The analysis showed that nearly all biotinylated polystyrene beads were bound to fluorescent microspheres . The observed binding included large aggregates of beads and microspheres together. Few instances of non-specific aggregation were observed. This illustrative example shows that fluorescent nanocrystals may be operably bound to polymeric microspheres comprising affinity ligand in forming fluorescent microspheres which retain the ability of the affinity ligand to interact with a analyte for which it has binding specificity. In another example, commercially-obtained polymeric microspheres comprising polymer-coated magnetite may be used in the process according to Examples 3 & 4 herein, in physically entrapping fluorescent nanocrystals in forming fluorescent microspheres. The resultant fluorescent microspheres may further comprise affinity ligand by using a process according to Examples 4 & 5 herein.
EXAMPLE 7 This example illustrates one embodiment of a method of using the fluorescent microspheres according to the present invention to provide an identifiable fluorescence signal pattern. For example, semiconductor nanocrystals can be produced in several uniform sizes, with each size comprising a homogeneous population capable of emitting a discrete fluorescence emission of high quantum yield (i.e., the particular color emitted is primarily dependent on the size of the nanocrystal) , but wherein the heterogeneous population (a combination of homogeneous populations) can be excited with a single wavelength spectrum of light, and can emit a distinguishably detectable ("discrete") fluorescence emission spectra representative of the homogenous populations. Likewise, depending on the dopant for a doped metal oxide nanocrystal, a homogeneous population (e.g., containing the same type and amount of dopant) is capable of emitting a discrete fluorescence emission of high quantum yield, but wherein the heterogeneous population (a combination of homogeneous populations) can be excited with a single wavelength spectrum of light, and can emit a dis- tinguishably detectable fluorescence emission spectra representative of the homogenous populations. Thus, a fluorescent microsphere may comprise an identifiable fluorescence signal pattern comprised of one (e.g., capable of fluores- cing a single color) or more (capable of fluorescing in multicolor) homogeneous populations of fluorescent nanocrystals which comprise a part (component) of the fluorescent microsphere. For example, where the fluorescent microsphere comprises a homogeneous population of fluorescent nanocrystals, the fluorescent naocrystals may be dispersed over the general shape of the fluorescent micro- sphere, or may be spatially arranged (e.g., multiple deposits ("localizations") on the polymeric microsphere which may be controlled by controlling the availability and location of reactive functionalities on the polymeric micro- sphere to which the fluorescent nanocrystals become operably bound) in providing a fluorescence signal pattern comprised of a single color of fluorescence, and as measured by a peak intensity. Likewise, where the fluorescent microsphere com- prises a heterogeneous population of fluorescent nanocrystals, the fluorescent nanocrystals may be dispersed over the general shape of the fluorescent microsphere, or may be spatially arranged (e.g., multiple deposits ("localizations") on the polymeric microsphere which may be controlled by controlling the availability and location of reactive functionalities on the polymeric microsphere to which the fluorescent nanocrystals become operably bound) in providing a fluorescence signal pattern comprised of more than one color of (multicolor) fluorescence with each color capable of being detectably distinguishable from the other colors.
In another example, and where the fluorescent micro- sphere comprises a homogeneous population of fluorescent nanocrystals, the fluorescent nanocrystals may be dispersed by physical entrapment to cover the general shape of the fluorescent microsphere in providing a fluorescence signal pattern comprised of a single color of fluorescence, and as measured by a peak intensity. Likewise, where the fluorescent microsphere comprises a heterogeneous population of fluorescent nanocrystals, the fluorescent nanocrystals may be dispersed by physical entrapment to cover the general shape of the fluorescent microsphere in providing a fluorescence signal pattern comprised of more than one color of (multicolor) fluorescence with each color capable of being detectably distinguishable from the other color or colors by their peak emission spectra (e.g., are spectrally resolvable) .
Also, a fluorescence signal pattern emitted by one or more fluorescent microspheres may comprise a fluorescence signal pattern comprised of detectably distinguishable intensities of one or more colors. A code representative of the fluorescence signal pattern, and of the one or more fluorescent microspheres emitting the fluorescence signal pattern, may comprise an identifier (e.g., one or more numbers) for each color comprising the fluorescence signal pattern, and may further comprise an identifier representative of the intensity of each color comprising the fluorescence signal pattern (e.g., wherein the code comprises a combination of the identifiers, such as a string of numbers in a range of from about 2 numbers to about 100 numbers) .
Thus, an identifiable fluorescence signal pattern comprised of a plurality of colors (or colors and intensities) enables a large number of combinations and permutations which may be used to identify or track fluorescent microspheres exposed to an exciting light source and detection of the resultant fluorescence emission. Thus, fluorescent microspheres may be used in multidimensional array formats (e.g., micro- arrays) for detecting a plurality of analytes by depositing on and/or flowing the fluorescent microspheres in the desired array format, and utilizing an appropriate detection system to detectably distinguish the fluorescent signal patterns (e.g., as measured by number of events of fluorescence versus the intensity of fluorescence, using a fluorescence microscope with a video camera attachment and computer software program for manipulating and storing the data collected) .
EXAMPLE 8 This example illustrates another embodiment of a method of using the fluorescent microspheres according to the present invention for determining the presence or absence of a predetermined number of analytes in a sample. The determination may be qualitative or quantitative, depending on the assay format utilized. A predetermined number of analytes means a single analyte if it is desired to determine the presence or absence of that analyte alone; or more than one analyte when it is desired to determine the presence or absence of any one of multiple analytes. The fluorescent microspheres may comprise a homogenous population which is capable of fluorescing a peak emission (fluorescent signal pattern) when excited by an excitation light source, and further comprises affinity ligand having binding specificity for the analyte of which the presence or absence is to be determined. Alternatively, the fluorescent micro- spheres may comprise a heterogeneous population comprising multiple homogenous populations, wherein each homogenous population is capable of emitting a fluorescence signal pattern distinguishable from the fluorescence signal pat- terns of other homogenous populations comprising the heterogeneous population, and wherein the heterogeneous population may be excited by a single excitation light source. Each homogenous population may further comprise affinity ligand having binding specificity for an analyte of the predeter- mined number of analytes of which the presence or absence is to be determined. Thus, a method of using the fluorescent microspheres for determining the presence or absence of a predetermined number of analytes in a sample comprises :
(a) contacting the fluorescent microspheres with the sample under suitable conditions for the fluorescent microspheres to bind the predetermined number of analytes, if present in the sample, in forming complexes;
(b) exposing the complexes, if formed, to an excitation wavelength light source suitable for exciting the fluores- cent microspheres of the complexes to emit a fluorescence signal pattern; and
(c) detecting the fluorescence signal pattern emitted by the complexes, if present, by a detection means for detecting the fluorescence signal pattern; wherein detection of the fluorescent signal pattern is indicative of the presence of an analyte of the predetermined number of analytes . Wherein the presence of an analyte is detected, the method may further comprise quan- titating the amount of analyte by measuring the intensity of the fluorescence signal pattern emitted from the fluorescent microspheres bound to the analyte, and relating the intensity measured to the amount of analyte. The method may be used in a fluorescent detection system selected from the group consisting of an affinity-based assay, fluorescence- based immunoassay, fluorescent staining (e.g., immuno- fluorescent staining on a glass slide) , flow cytometry, a hybridization-based assay, and the like.
In a preferred embodiment, the fluorescence signal pattern comprises one or more fluorescence emission peaks, wherein each peak has a narrow spectral band (e.g. between about 4 nm to about 50 nm) in the range of from about 400 nm to about 800 nm. A preferred excitation light source for exciting the fluorescent microspheres according to the present invention is in the range of about 300 nm to about
400 nm; and in a more preferred embodiment, from about 360 nm to about 365 nm. Any fluorescence signal pattern emitted is then detected and imaged by appropriate detection means or system (e.g., one or more of: photodetector, filter, charge couple device camera (CCD camera) fluorimeter, fluorescence microscope, a fluorescence cube, a computer for manipulating fluorescence signal pattern data collected, and a combination thereof) .
EXAMPLE 9
In this example, illustrated is an embodiment of a kit which comprises one or a combination of types of fluorescent microspheres according to the present invention. For example, a kit may be provided which comprises one or more separate containers, wherein each container has contents comprising fluorescent microspheres capable of fluorescing a specific fluorescence pattern (e.g., one color or a desired combination of colors) . In one example, the fluorescent microspheres may comprise reactive functionalities which allow a user of the kit to operably bind affinity ligand of the user's choice to the fluorescent microspheres. Thus, the kit may provide the user with the flexibility to prepare a customized detection reagent comprising the fluorescent microspheres operably bound to affinity ligand of the user's choice. In further illustration, the kit may comprise 3 containers, wherein one container has contents comprising fluorescent microspheres capable of fluorescing red; a second container has contents comprising fluorescent micro- spheres capable of fluorescing yellow; a third container has contents comprising fluorescent microspheres capable of fluorescing green; wherein the contents of each container are capable of being operably bound to affinity ligand via the reactive functionalities of the respective type (e.g., fluorescing color) of fluorescent microspheres. Alternatively, the different types (e.g., the three types distinguished above by color of fluorescence/specific fluorescence pattern) may all be contents of a single container . In another example, the fluorescent microspheres contained in each separate container comprising the kit further comprise affinity ligand operably bound thereto. Thus, the fluorescent microspheres may be used as detection reagents as described herein in more detail. For example, the kit may comprise a single container having contents comprising fluorescent microspheres further comprising affinity ligand having binding specificity for a desired analyte; or may comprise more than one type of fluorescent microspheres wherein each individual type has affinity ligand having a different binding specificity than affinity ligand of the other types of fluorescent microspheres in the single container. Alternatively, each of plurality of types of fluorescent microspheres (differing in binding specifi- city) may be individually packaged in a separate container, such that the kit is now comprised of a plurality of containers .
The foregoing description of the specific embodiments of the present invention have been described in detail for purposes of illustration. In view of the descriptions and illustrations, others skilled in the art can, by applying, current knowledge, readily modify and/or adapt the present invention for various applications without departing from the basic concept, and therefore such modifications and/or adaptations are intended to be within the meaning and scope of the appended claims .
What is claimed:

Claims

1. A fluorescent microsphere comprised of a polymeric microsphere which is labeled with a plurality of fluorescent nanocrystals; wherein the plurality of fluorescent nanocrystals are either physically entrapped in, or are operably bound to, the polymeric microsphere; and wherein the fluorescent nanocrystals further comprise reactive functionalities .
2. A fluorescent microsphere comprised of a plurality of fluorescent nanocrystals operably bound to a polymeric microsphere, wherein the fluorescent nanocrystals further comprise reactive functionalities.
3. A fluorescent microsphere comprised of a plurality of fluorescent nanocrystals physically entrapped in a polymeric microsphere, wherein the fluorescent nanocrystals further comprise reactive functionalities.
4. The fluorescent microsphere according to any of claims 1-3, wherein the fluorescent nanocrystals are functionalized with a plurality of molecules to provide the reactive functionalities, and wherein the plurality of molecules is selected from the group consisting of carboxylic acid, diaminocarboxylic acid, monoaminocarboxylic acid, and a combination thereof.
5. The fluorescent microsphere according to any of claims 1-3, wherein the polymeric microsphere comprises multiple molecules of reactive functionality comprising a free chemical group.
6. The fluorescent microsphere according to any of claims 1-3, wherein the polymeric microsphere comprises multiple molecules of reactive functionality comprising a free chemical group, and the fluorescent nanocrystals comprise multiple molecules of reactive functionality comprising a reactive chemical group which are operably bound to the reactive functionality of the polymeric microsphere.
7. The fluorescent microsphere according to any of claims 1-3, wherein the fluorescent nanocrystals comprise a homogenous population.
8. The fluorescent microsphere according to any of claims 1- 3, wherein the fluorescent nanocrystals comprise heterogeneous population.
9. The fluorescent microsphere according to any of claims 1-3, further comprising affinity ligand operably bound thereto.
10. The fluorescent microsphere according to any of claims 1-3, wherein the fluorescent nanocrystals have an average particle size in a range of from approximately 1 nm to approximately 20 nm.
11. The fluorescent microsphere according to any of claims 1-3, wherein the fluorescent nanocrystals comprise semiconductor nanocrystals.
12. The fluorescent microsphere according to claim 11, wherein the fluorescent nanocrystals have a particle size that varies by less than 4%.
13. The fluorescent microsphere according to any of claims 1-3, wherein the fluorescent nanocrystals comprise doped metal oxide nanocrystals.
14. The fluorescent microsphere according to claim 13 , wherein the fluorescent microsphere is magnetic.
15. The fluorescent microsphere according to any of claims 1-3, wherein the polymeric microsphere comprises a material selected from the group consisting of latex, acrylic, a glass/polymer composite, a thermoplastic, a polymeric material in combination with a magnetic material, and a combination thereof .
16. The fluorescent microsphere according to claim 15, wherein the polymeric microsphere further comprises carbon black in a weight percentage of from about 0.5 to about 5.
17. The fluorescent microsphere according to any of claims 1-3, wherein the polymeric microsphere comprises a combination of a polymeric material and a magnetic material selected from the group consisting of a polymeric material into which is embedded the magnetic material, a magnetic material core and a polymeric material coating, a polymeric material core with a magnetic material layer thereon and a polymeric material coating over the magnetic layer, and a magnetic material dispersed within a polymeric material.
18. The fluorescent microsphere according to claim 7, wherein the homogenous population of fluorescent nanocrystals, when excited with an excitation light source, emit a fluorescence signal pattern.
19. A plurality of fluorescent microspheres, wherein a fluorescence microsphere of the plurality is according to any of claims 1-9, which when excited with an excitation light source, emit a fluorescence signal pattern.
20. The fluorescent microspheres according to claim 19, wherein the fluorescence signal pattern comprises multicolor fluorescence and detectably distinguishable intensities .
21. The fluorescent microspheres according to claims 19 or 20, wherein a code representative of the fluorescence signal pattern, and of the fluorescent microspheres which emit the fluorescence signal pattern, comprises an identifier for each color comprising the fluorescence signal pattern, and an identifier for the intensity of each color.
22. The fluorescent microsphere according to claim 21, wherein the code comprises a string of numbers.
23. A code representative of the fluorescence microspheres according to claim 21.
24. A code representative of the fluorescence microspheres according to claim 22.
25. A kit comprising one or more containers, wherein the one or more containers is selected from the group consisting of a container having contents comprising fluorescence microspheres capable of fluorescing a specific fluorescence pattern, and a plurality of containers with each container having contents comprising fluorescence microspheres capable of fluorescing a specific fluorescence pattern different than the specific fluorescence pattern of other contents of the plurality of containers; wherein a fluorescent microsphere is comprised of a polymeric microsphere which is labeled with a plurality of fluorescent nanocrystals; wherein the plurality of fluorescent nanocrystals are either physically entrapped in, or are operably bound to, the polymeric microsphere; and wherein the fluorescent nanocrystals further comprise reactive functionalities.
26. The kit according to claim 25 wherein the fluorescent microspheres are selected from the group consisting of fluorescent microspheres with reactive functionalities, fluorescent microspheres further comprising affinity ligand operably bound thereto, and a combination thereof.
27. The kit according to claim 25, wherein the kit comprises a single container, and the container has contents comprising fluorescent microspheres capable of fluorescing a specific fluorescence pattern comprising a single color when excited by an excitation light source.
28. The kit according to claim 25, wherein the kit comprises a plurality of containers with each container having contents comprising fluorescence microspheres capable of fluorescing a specific fluorescence pattern comprising a color different than the specific fluorescence pattern of contents of other containers of the plurality of containers.
29. A method of producing fluorescent microspheres, wherein a fluorescent microsphere comprises a plurality of fluorescent nanocrystals operably bound to a polymeric microsphere, wherein the method comprises contacting polymeric microspheres with a plurality of fluorescent nanocrystals under suitable conditions for the plurality of fluorescent nanocrystals to become operably bound to the polymeric microspheres.
30. The method according to claim 29, wherein the polymeric microspheres comprises multiple molecules of reactive functionality comprising a free chemical group, and the fluorescent nanocrystals comprise multiple molecules of reactive functionality comprising a reactive chemical group which become operably bound to the reactive functionality of the polymeric microspheres .
31. A method of producing a fluorescent microspheres, wherein a fluorescent microsphere comprises a plurality of fluorescent nanocrystals embedded in a polymeric microspheres, wherein the method comprises: exposing the polymeric microspheres under suitable conditions to cause swelling, and an increase in size of pores, of the polymeric microspheres, and for allowing the fluorescent nanocrystals to enter into the pores of the swelled polymeric microspheres; and exposing the swelled polymeric microspheres to suitable conditions to cause the polymeric micropsheres to become unswollen in decreasing size of the pores, thereby physically entrapping fluorescent nanocrystals which may be present in the pores .
32. The method according to claim 31, wherein the suitable conditions for swelling the polymeric microspheres comprises a temperature sufficient to soften a polymeric composition of the polymeric microspheres, and wherein the temperature is below a melting point of the polymer composition.
33. The method according to claim 32, wherein the suitable conditions for unswelling the polymeric microspheres comprises reducing the temperature to a temperature sufficient to decrease the pore size for physically entrapping fluorescent nanocrystals.
34. The method according to claim 32, wherein the suitable conditions further comprises pressurizing the polymeric microspheres to a pressure above atmospheric pressure .
35. The method according to claim 34, wherein the suitable conditions for unswelling the polymeric microspheres comprises reducing the temperature to a temperature sufficient to decrease the pore size for physically entrapping fluorescent nanocrystals, and reducing the pressure to atmospheric pressure.
36. The method according to claim 31, wherein the suitable conditions for swelling the polymeric microspheres comprises contacting the polymeric microspheres with an organic medium comprising one or more organic solvents which are able to swell the polymeric microspheres.
37. The method according to claim 36, wherein the suitable conditions for unswelling the polymeric microspheres comprises removing the organic medium from contact with the polymeric microspheres .
38. The method according to claims 29 or 31, wherein the polymeric microspheres comprise multiple molecules of reactive functionality comprising a free chemical group.
39. The method according to claims 29 or 31, wherein the fluorescent nanocrystals comprise a homogenous population.
40. The method according to claims 29 or 31, wherein the fluorescent nanocrystals comprise a heterogeneous population.
41. The method according to claims 29 or 31, wherein the fluorescent microspheres further comprises affinity ligand operably bound thereto.
42. The method according to claims 29 or 31, wherein the fluorescent nanocrystals comprise semiconductor nanocrystals.
43. The method according to claims 29 or 31, wherein the fluorescent nanocrystals comprise doped metal oxide nanocrystals .
44. The method according to claims 29 or 31, wherein the fluorescent microspheres are magnetic.
45. The method according to claims 29 or 31, wherein the polymeric microspheres comprise a material selected from the group consisting of latex, acrylic, a glass/polymer composite, a thermoplastic, a polymeric material in combination with a magnetic material, and a combination thereof .
46. The method according to claims 29 or 31, wherein the polymeric microspheres further comprise carbon black in a weight percentage of from about 0.5 to about 5.
47. The method according to claims 29 or 31, wherein the polymeric microspheres comprise a combination of a polymeric material and a magnetic material selected from the group consisting of a polymeric material into which is embedded the magnetic material, a magnetic material core and a polymeric material coating, a polymeric material core with a magnetic material layer thereon and" a polymeric material coating over the magnetic layer, and a magnetic material dispersed within a polymeric material.
48. A method of using fluorescent microspheres for determining the presence or absence of a predetermined number of analytes in a sample, wherein a fluorescent microsphere is comprised of a polymeric microsphere which is labeled with a plurality of fluorescent nanocrystals that are either physically entrapped in, or are operably bound to, the polymeric microsphere, and wherein a fluorescent microsphere further comprises affinity ligand operably bound thereto, the method comprising:
(a) contacting the fluorescent microspheres with the sample under suitable conditions for the fluorescent microspheres to bind the predetermined number of analytes, if present in the sample, in forming complexes;
(b) exposing the complexes, if formed, to an excitation wavelength light source suitable for exciting the fluorescent microspheres of the complexes to emit a fluorescence signal pattern; and
(c) detecting the fluorescence signal pattern emitted by the complexes, if present, by a detection means for detecting the fluorescence signal pattern; wherein detection of the fluorescent signal pattern is indicative of the presence of an analyte of the predetermined number of analytes .
49. The method according to claim 48, wherein the presence of an analyte is detected, and the method further comprises quantitating an amount of the analyte detected by measuring the intensity of the fluorescence signal pattern emitted from the fluorescent microspheres bound to the analyte.
50. The method according to claim 48, wherein the method is performed using a fluorescent detection system selected from the group consisting of an affinity-based assay, fluorescence-based immunoassay, fluorescent staining, flow cytometry, and a hybridization-based assay.
51. The method according to claim 48, wherein the fluorescence signal pattern comprises one or more fluorescence emission peaks, wherein each peak has a narrow spectral band in the range of from about 400 nm to about 800 nm.
52. The method according to claim 48, wherein the excitation wavelength light source for exciting the fluorescent microspheres is a wavelength spectrum in the range of about 300 nm to about 400 nm.
53. The method according to claim 48, wherein the detection means is selected from the group consisting of a photodetector, a filter, a charge couple device camera, a fluorimeter, a fluorescence microscope, a fluorescence cube, a computer for manipulating fluorescence signal pattern data collected, and a combination thereof.
PCT/US2001/016678 2000-05-24 2001-05-23 tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES WO2001089585A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001264860A AU2001264860A1 (en) 2000-05-24 2001-05-23 Tluorescent nanocrystal-labelled microspheres for fluorescence analyses

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/577,761 US6309701B1 (en) 1998-11-10 2000-05-24 Fluorescent nanocrystal-labeled microspheres for fluorescence analyses
US09/577,761 2000-05-24
US09/633,953 US6548171B1 (en) 1998-11-10 2000-08-08 Fluorescent nanocrystal-embedded microspheres for fluorescence analyses
US09/633,953 2000-08-08

Publications (1)

Publication Number Publication Date
WO2001089585A1 true WO2001089585A1 (en) 2001-11-29

Family

ID=27077325

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016678 WO2001089585A1 (en) 2000-05-24 2001-05-23 tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES

Country Status (2)

Country Link
AU (1) AU2001264860A1 (en)
WO (1) WO2001089585A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908737B2 (en) 1999-04-15 2005-06-21 Vitra Bioscience, Inc. Systems and methods of conducting multiplexed experiments
WO2005107818A2 (en) * 2004-04-30 2005-11-17 University Of Florida Nanoparticles and their use for multifunctional bioimaging
US7253435B2 (en) 1999-04-15 2007-08-07 Millipore Corporation Particles with light-polarizing codes
WO2008023305A2 (en) * 2006-08-25 2008-02-28 Koninklijke Philips Electronics N. V. Contrast agent comprising a tm2+ containing luminescent substance for optical imaging
EP2196544A1 (en) 2001-11-21 2010-06-16 Applied Biosystems, LLC Kit for ligation detection assays using codeable labels
CN103289469A (en) * 2012-02-22 2013-09-11 中国科学院理化技术研究所 Fluorescent anti-counterfeiting ink based on light-emitting quantum dots and preparation method as well as application thereof
CN103788942A (en) * 2014-02-24 2014-05-14 苏州大学 Eu<3+> and rhodamine 6G doped polymer fluorescent encoding microsphere and preparation method
US9360476B2 (en) 2006-12-19 2016-06-07 Fio Corporation Microfluidic system and method to test for target molecules in a biological sample
US9459200B2 (en) 2008-08-29 2016-10-04 Fio Corporation Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples
US9695482B2 (en) 2007-10-12 2017-07-04 Fio Coporation Flow focusing method and system for forming concentrated volumes of microbeads, and microbeads formed further thereto
US9792809B2 (en) 2008-06-25 2017-10-17 Fio Corporation Bio-threat alert system
US9805165B2 (en) 2009-01-13 2017-10-31 Fio Corporation Handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test
WO2019237406A1 (en) * 2018-06-12 2019-12-19 苏州百源基因技术有限公司 Dye encoding method based on fluorescently-labeled amino acid
CN112048096A (en) * 2020-09-10 2020-12-08 南京基蛋生物医药有限公司 Preparation method of polystyrene hydrophilic fluorescent microspheres, prepared microspheres and application
CN113136124A (en) * 2021-04-22 2021-07-20 维德斯新材料(上海)有限公司 Texture coating and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194305A (en) * 1990-10-11 1993-03-16 Tokai Kogyo Kaisha Moldings and process for manufacturing the same
US5747349A (en) * 1996-03-20 1998-05-05 University Of Washington Fluorescent reporter beads for fluid analysis
US5751018A (en) * 1991-11-22 1998-05-12 The Regents Of The University Of California Semiconductor nanocrystals covalently bound to solid inorganic surfaces using self-assembled monolayers
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6114038A (en) * 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194305A (en) * 1990-10-11 1993-03-16 Tokai Kogyo Kaisha Moldings and process for manufacturing the same
US5751018A (en) * 1991-11-22 1998-05-12 The Regents Of The University Of California Semiconductor nanocrystals covalently bound to solid inorganic surfaces using self-assembled monolayers
US5747349A (en) * 1996-03-20 1998-05-05 University Of Washington Fluorescent reporter beads for fluid analysis
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6114038A (en) * 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253435B2 (en) 1999-04-15 2007-08-07 Millipore Corporation Particles with light-polarizing codes
US6908737B2 (en) 1999-04-15 2005-06-21 Vitra Bioscience, Inc. Systems and methods of conducting multiplexed experiments
EP2196544A1 (en) 2001-11-21 2010-06-16 Applied Biosystems, LLC Kit for ligation detection assays using codeable labels
WO2005107818A3 (en) * 2004-04-30 2007-08-23 Univ Florida Nanoparticles and their use for multifunctional bioimaging
US8128908B2 (en) 2004-04-30 2012-03-06 University Of Florida Research Foundation, Inc. Nanoparticles and their use for multifunctional bioimaging
WO2005107818A2 (en) * 2004-04-30 2005-11-17 University Of Florida Nanoparticles and their use for multifunctional bioimaging
WO2008023305A2 (en) * 2006-08-25 2008-02-28 Koninklijke Philips Electronics N. V. Contrast agent comprising a tm2+ containing luminescent substance for optical imaging
WO2008023305A3 (en) * 2006-08-25 2008-10-16 Koninkl Philips Electronics Nv Contrast agent comprising a tm2+ containing luminescent substance for optical imaging
US9360476B2 (en) 2006-12-19 2016-06-07 Fio Corporation Microfluidic system and method to test for target molecules in a biological sample
US9695482B2 (en) 2007-10-12 2017-07-04 Fio Coporation Flow focusing method and system for forming concentrated volumes of microbeads, and microbeads formed further thereto
US9792809B2 (en) 2008-06-25 2017-10-17 Fio Corporation Bio-threat alert system
US9945837B2 (en) 2008-08-29 2018-04-17 Fio Corporation Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples
US9459200B2 (en) 2008-08-29 2016-10-04 Fio Corporation Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples
US9805165B2 (en) 2009-01-13 2017-10-31 Fio Corporation Handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test
US11385219B2 (en) 2009-01-13 2022-07-12 Fio Corporation Handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test
CN103289469A (en) * 2012-02-22 2013-09-11 中国科学院理化技术研究所 Fluorescent anti-counterfeiting ink based on light-emitting quantum dots and preparation method as well as application thereof
CN103788942B (en) * 2014-02-24 2015-09-23 苏州大学 Doping Eu 3+with high molecular fluorescent coding microball and the preparation method of rhodamine 6G
CN103788942A (en) * 2014-02-24 2014-05-14 苏州大学 Eu<3+> and rhodamine 6G doped polymer fluorescent encoding microsphere and preparation method
WO2019237406A1 (en) * 2018-06-12 2019-12-19 苏州百源基因技术有限公司 Dye encoding method based on fluorescently-labeled amino acid
CN112048096A (en) * 2020-09-10 2020-12-08 南京基蛋生物医药有限公司 Preparation method of polystyrene hydrophilic fluorescent microspheres, prepared microspheres and application
CN112048096B (en) * 2020-09-10 2022-07-26 南京基蛋生物医药有限公司 Preparation method of polystyrene hydrophilic fluorescent microspheres, prepared microspheres and application
CN113136124A (en) * 2021-04-22 2021-07-20 维德斯新材料(上海)有限公司 Texture coating and preparation method and application thereof

Also Published As

Publication number Publication date
AU2001264860A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
US6680211B2 (en) Fluorescent nanocrystal-embedded microspheres for fluorescence analysis
US6309701B1 (en) Fluorescent nanocrystal-labeled microspheres for fluorescence analyses
JP5254928B2 (en) Nanocrystal
US8092859B2 (en) Synthesis of highly luminescent colloidal particles
US6630307B2 (en) Method of detecting an analyte in a sample using semiconductor nanocrystals as a detectable label
AU2002360812B2 (en) Multianalyte molecular analysis using application-specific random particle arrays
US7214428B2 (en) Highly luminescent functionalized semiconductor nanocrystals for biological and physical applications
WO2001089585A1 (en) tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES
US20010046602A1 (en) Magnetically-responsive microspheres
WO2001093916A1 (en) Purification of functionalized fluorescent nanocrystals
US20130137114A1 (en) Bioprobe, Method of Preparing the Bioprobe, and Analysis Apparatus and Method Using the Bioprobe
JP2003523718A (en) Inventory control
EP1931593A1 (en) Multiple component nanoparticles for multiplexed signaling and optical encoding
JP2007506084A (en) Nanoparticle conjugate and method for producing the same
EP3054297A1 (en) Fluorescence-labeled particle

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP